Document:

EX-4.4

 Exhibit 4.4 

DATED November 8th, 2021 

WARRANT INSTRUMENT 
 PERIMETER
SOLUTIONS SA 
  

 TABLE OF CONTENTS 

 

							
	1.	  	 DEFINITIONS AND INTERPRETATION
	  	 	1	 
			
	2.	  	 CONSTITUTION AND FORM OF WARRANTS
	  	 	5	 
			
	3.	  	 WARRANT CERTIFICATES
	  	 	6	 
			
	4.	  	 EXERCISE OF WARRANTS
	  	 	6	 
			
	5.	  	 UNDERTAKINGS
	  	 	9	 
			
	6.	  	 ADJUSTMENT OF SUBSCRIPTION RIGHTS
	  	 	9	 
			
	7.	  	 MANDATORY REDEMPTION
	  	 	10	 
			
	8.	  	 GENERAL OFFERS AND LIQUIDATION
	  	 	10	 
			
	9.	  	 TRANSFER AND TITLE
	  	 	11	 
			
	10.	  	 MEETINGS OF WARRANTHOLDERS
	  	 	11	 
			
	11.	  	 MODIFICATIONS
	  	 	13	 
			
	12.	  	 PURCHASE, SURRENDER AND CANCELLATION
	  	 	13	 
			
	13.	  	 AVAILABILITY OF INSTRUMENT AND NOTICES
	  	 	13	 
			
	14.	  	 PURCHASE OF ORDINARY SHARES BY THE COMPANY
	  	 	14	 
			
	15.	  	 ENFORCEMENT
	  	 	14	 
			
	16.	  	 GOVERNING LAW
	  	 	14	 
			
	17.	  	 SEVERABILITY
	  	 	15	 
			
	18.	  	 FORCE MAJEURE
	  	 	15	 
			
	19.	  	 CONCERNING THE RECEIVING AGENT
	  	 	15	 
		
	 SCHEDULE 1 FORM OF WARRANT CERTIFICATE
	  	 	17	 
		
	 SCHEDULE 2 REGISTRATION, TRANSFER AND TRANSMISSION
	  	 	22	 
		
	 SCHEDULE 3 CONCERNING THE RIGHTS AGENT; MERGER, CONSOLIDATION OR CHANGE OF
RECEIVING AGENT
	  	 	27	 

 THIS WARRANT INSTRUMENT IS EXECUTED ON November 8th,
2021 BY 
 Perimeter Solutions SA, a public limited company (société anonyme) incorporated and existing under the
laws of the Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies’ Register (Registre de Commerce et des Sociétés, Luxembourg) under number B 256.548, whose registered office is at 12E, rue
Guillaume Kroll, L-1882 Luxembourg, Grand Duchy of Luxembourg (the “Company”), Computershare Inc., a Delaware corporation (“Computershare”) and its wholly-owned subsidiary
Computershare Trust Company, N.A., a federally chartered trust company (together with Computershare, the “Receiving Agent’). 

BACKGROUND 
  

	(A)	 By a resolution of the Board (as defined below) passed on November 1st, 2021 and a resolution of the sole shareholder of the Company taken in front of a notary in the Grand Duchy of Luxembourg on November 2nd, 2021,
the issue by the Company of up to 34,020,000 Warrants (as defined below) has been authorized, subject to the terms and conditions as set out in this Instrument. 

 

	(B)	 As contemplated by the business combination agreement (the “Business Combination Agreement”)
entered into as of June 15, 2021, by and among the Company, EverArc Holdings Ltd. (“EHL”), EverArc (BVI) Merger Sub Limited and SK Invictus Holdings S.à r.l., at the Merger Effective Time (as defined in the Business
Combination Agreement), each EverArc Warrant (as defined in the Business Combination Agreement) that is outstanding immediately prior to the Merger Effective Time shall cease to represent a right to acquire the number of EverArc Shares (as defined
in the Business Combination Agreement) set forth in such EverArc Warrant and shall be converted, at the Merger Effective Time, into a right to acquire Holdco Ordinary Shares on substantially the same terms as were in effect immediately prior to the
Merger Effective Time under the terms of the EverArc Warrant Instrument (as defined in the Business Combination Agreement). 

  

	(C)	 In order to implement the terms of the Business Combination Agreement, the Company has accordingly determined
to execute this Instrument (as modified, supplemented, amended or amended and restated from time to time, the “Instrument”) to set out the rights and interests of the Warrantholders (as defined below) and to incorporate the duties,
obligations and immunities of the Receiving Agent appointed under this Instrument. 

 OPERATIVE PROVISIONS 

 

	1.	 DEFINITIONS AND INTERPRETATION 

 

	1.1	 In this Instrument: 

“Acquisition” means the consummation of the transactions contemplated by the Business Combination Agreement; 

“Adjustment Percentage” has the meaning given in clause 6.1; 

“Admission” means admission of the Ordinary Shares and Warrants to trading on the Trading Market; 

  
 1 

 “Articles” means the articles of association of the Company in force from
time to time; 
 “Average Price” means for any security, as of any date or relevant period (as applicable): (i) in
respect of Ordinary Shares or any other security, the volume weighted average price for such security on the Trading Market as reported by Bloomberg through its “Volume at Price” functions; (ii) if the Directors determine in
their discretion that the Trading Market is not the principal securities exchange or trading market for that security, the volume weighted average price of that security on the principal securities exchange or trading market on which that
security is listed or traded as reported by Bloomberg through its “Volume at Price” functions; (iii) if the foregoing do not apply, the last closing trade price of that security in the over-the-counter market on the electronic bulletin board for that security as reported by Bloomberg; or (iv) if no last closing trade price is reported for that security by Bloomberg, the last closing
ask price of that security as reported by Bloomberg. If the Average Price cannot be calculated for that security on that date on any of the foregoing bases, the Average Price of that security on such date shall be the fair market value as mutually
determined by the Company and the Warrantholders representing a majority of the Ordinary Shares outstanding under the Warrants; 

“Business Day” means any day (excluding a Saturday or a Sunday) on which banks in New York, New York and the Grand Duchy of
Luxembourg are open for business; 
 “Directors” or “Board” means the board of directors of the Company
from time to time; 
 “Exchange Act” means the US Securities Exchange Act of 1934, as amended; 

“Exercise Price” means US$ 12.00 per Ordinary Share (or such adjusted price as may be determined from to time in accordance
with the provisions of clause 6), which is the aggregate amount payable for each Minimum Exercise Amount; 
 “Form of
Nomination” means in relation to any Warrant the form of nomination attached to the Warrant Certificate; 
 “Listing
Rules” means the listing rules and regulations of the Trading Market; 
 “Minimum Exercise Amount” means, as of the
applicable time of determination, with respect to each exercise of Warrants, the number of Warrants necessary for a Warrantholder to exercise to receive one whole Ordinary Share upon such exercise as determined by the Board; 

“Ordinary Shares” means the ordinary shares having a nominal value of USD 1.00 each in the share capital of the Company (which
for these purposes, for the avoidance of doubt, shall include the Company in such form as it exists following any continuation, merger, consolidation or similar action under the laws of the Grand Duchy of Luxembourg or any relevant foreign
jurisdiction) and (ii) any capital shares into which such ordinary shares shall have been changed (including, for the avoidance of doubt, following any continuation, merger, consolidation or similar action under the laws of the Grand Duchy of
Luxembourg or any relevant foreign jurisdiction) or any share capital resulting from a reclassification of such ordinary shares; 

  
 2 

 “Portion” means, as of the applicable time of determination, (as
applicable) (i) from and after the date hereof through the time immediately preceding the first adjustment (if any) under clause 6, one fourth (1/4th), (ii) from and after the time of
the first adjustment (if any) under clause 6 until the next adjustment thereunder, the product of (x) one fourth (1/4th) multiplied by(y) the applicable Adjustment Percentage that is
calculated in respect of such first adjustment or (iii) from and after the time of each successive adjustment (if any) under clause 6, the product of (x) the fraction then in effect as previously determined pursuant to the immediately
preceding clause (ii) or this clause (iii) (as the case may be) multiplied by (y) the applicable Adjustment Percentage that is calculated in respect of such applicable adjustment, subject to adjustment in accordance with
clause 6.3; 
 “Receiving Agent” has the meaning given in the preamble; 

“Redemption Event” has the meaning given in clause 7.2; 

“Redemption Notice” means the notice to Warrantholders notifying the occurrence of a Redemption Event to be given pursuant to
clause 7.3; 
 “Redemption Trigger Price” means US$18.00 (subject to adjustment pursuant to clause 7.4); 

“Register” means the register of Warrantholders required to be maintained pursuant to clause 9.1; 

“Registrar” means Computershare Inc. or such person or persons appointed by the Company from time to time to maintain the
Register; 
 “Rule 144” means Rule 144 promulgated under the Securities Act (or a successor rule thereto); 

“Rule 144A” means Rule 144A promulgated under the Securities Act (or a successor rule thereto); 

“Securities Act” means the U.S. Securities Act of 1933, as amended; 

“Subscription Notice” means in relation to any Warrant the notice of subscription attached to the Warrant Certificate; 

“Subscription Period” means the period commencing on the Business Day following the date of completion of the Acquisition and
ending on the earlier to occur of (i) 5:00 p.m., Eastern time, on the third anniversary of the completion of the Acquisition and (ii) such earlier date as determined by this Instrument provided that if such day is not a Trading Day, the
Trading Day immediately following such day; 
 “Subscription Rights” means the rights to subscribe for Ordinary Shares
granted by the Company to Warrantholders pursuant to this Instrument; 
 “Trading Day” means a day on which the Trading
Market (or such other applicable securities exchange or quotation system on which the Ordinary Shares or Warrants are listed) is open for business (other than a day on which the Trading Market (or such other applicable securities exchange or
quotation system) is scheduled to or does close prior to its regular weekday closing time); 

  
 3 

 
“Trading Market” means the national stock exchange on which the Holdco Ordinary Shares will be listed for trading, which shall initially be the New York Stock Exchange (NYSE);

 “U.S. Investment Company Act” means the U.S. Investment Company Act of 1940, as amended, and related rules; 

“U.S. Person” has the meaning given to the term “U.S. Person” in Regulation S; 

“Warrant Certificate” means a certificate evidencing a holding of Warrants, such certificate being in or substantially in the
form set out in Schedule 1; 
 “Warrantholder” means in relation to any Warrant, the person or persons who is or are
for the time being the registered holder or joint holders of such Warrant in the Register; and 
 “Warrantholder Resolution”
means: 
  

	 	a)	 a resolution passed at a meeting of the Warrantholders duly convened and passed by a simple majority of the
votes cast, whether on a show of hands or on a poll; or 

  

	 	b)	 a resolution consented to in writing by Warrantholders representing a majority of the votes of shares entitled
to vote thereon. 

 “Warrants” means each of the warrants of the Company constituted by this Instrument
and all rights conferred by this Instrument. 
  

	1.2	 The clause headings are used for guidance only and shall not affect the meaning or interpretation of any part
of this Instrument. 

  

	1.3	 Reference to clauses, sub clauses and schedules in this Instrument are references to the clauses, sub clauses
and schedules of and to this Instrument. 

  

	1.4	 References to any statute or statutory provision includes references to that statute or statutory provision as
it may be amended, extended or re-enacted from time to time and shall extend to any rules, orders, regulations or delegated legislation made thereunder. 

 

	1.5	 Words importing the singular shall include the plural and vice versa; words importing the masculine shall
include the feminine and neuter and vice versa; words importing persons shall include bodies corporate, unincorporated associations and partnerships. 

  

	1.6	 Any register, index, minute book or book of account required to be kept by this Instrument shall be kept, and
inspection thereof shall be allowed and copies shall be supplied, in such form and manner and subject to such precautions as would from time to time be permissible or required if it were a register, index, minute book or book of account required to
be kept by the Luxembourg law of 10 August 1915 on commercial companies (as amended) (the “Law”) and references to such records in the Instrument shall be construed accordingly. 

  
 4 

	1.7	 A Warrant is “outstanding” unless the Subscription Rights attached to such Warrant have been
exercised in full or have lapsed in accordance with the provisions of this Instrument. 

  

	1.8	 Any reference to “writing” or “written” includes any method of reproducing words or text in
a legible and non-transitory form but shall not include e-mail. 

  

	1.9	 All references to “EUR” are to the lawful currency of the European Union as at the date of this
Instrument and all references to “$” or “US$” are to lawful currency of the United States of America as at the date of this instrument. 

  

	1.10	 References to times of the day are to Eastern Time in the United States of America and references to a day are
to a period of 24 hours running from midnight to midnight. 

  

	1.11	 Any reference to “Company” includes the Company in such form as it exists following any continuation,
merger, consolidation or similar action under the laws of the Grand Duchy of Luxembourg or any relevant foreign jurisdiction. 

  

	2.	 CONSTITUTION AND FORM OF WARRANTS 

 

	2.1	 The Company hereby creates and constitutes, pursuant to (a) a resolution of the Board passed on November 1st, 2021 and (b) a shareholder resolution passed on November 2nd, 2021, 34,020,000 warrants to subscribe for Ordinary Shares on the terms and
subject to the conditions of this Instrument. 

  

	2.2	 Each Warrant confers the right (but not the obligation) on the Warrantholder to subscribe for the applicable
Portion of an Ordinary Share during the Subscription Period on the terms and subject to the conditions set out in this Instrument. 

  

	2.3	 The Company undertakes to comply with the terms and conditions of this Instrument and specifically, but without
limitation, to do all such things and execute all such documents to the extent necessary in order to give effect to the exercise of any Subscription Rights in accordance with this Instrument. 

 

	2.4	 Upon the issue of any Warrant, the Company shall, or shall cause the Registrar to, enter the person or persons
to whom the Warrant is issued into the Register in respect of such Warrant. The registration of Warrants in the Register in a Warrantholder’s name will be evidenced by a Warrant Certificate issued by the Company to such Warrantholder.

  

	2.5	 The Company shall, upon exercise of all or any of the Warrants in accordance with clause 4 from time to time
during the Subscription Period, including, without limitation, the payment, in full, of the Exercise Price with respect thereto, forthwith issue the number of Ordinary Shares required to be issued in accordance with the terms of this Instrument.

  

	2.6	 The Warrants are issued subject to the Articles and otherwise on the terms and conditions of this Instrument,
which are binding upon the Company and each Warrantholder and all persons claiming through them. 

  
 5 

	3.	 WARRANT CERTIFICATES 

 

	3.1	 Every Warrant Certificate shall be in the form or substantially in the form set out in Schedule 1 (or such
other form as produced by the Registrar from time to time) and shall have endorsed thereon a Subscription Notice and Form of Nomination, each in the form or substantially in the form set out in Schedule 1. 

 

	3.2	 Where some, but not all, of the Warrants comprised in any Warrant Certificate are transferred or exercised the
Company shall issue, free of charge, to the relevant Warrantholder a new Warrant Certificate in accordance with the other provisions of this Instrument for the balance of the Warrants retained by such Warrantholder. 

 

	3.3	 All Warrant Certificates shall be executed by the Company either manually or by facsimile signature. Upon
written request by the Company, the Warrant Certificates shall be countersigned, either manually or by facsimile signature, by an authorized signatory of the Receiving Agent, but it shall not be necessary for the same signatory to countersign all of
the Warrant Certificates hereunder. 

  

	3.4	 If a Warrant Certificate is mutilated, defaced, lost, stolen or destroyed, it shall, at the discretion of the
Company, be replaced at the office of the Registrar on payment of such expenses as may reasonably be incurred by the Company, the Receiving Agent or the Registrar in connection therewith and on such terms as to evidence, indemnity and/or security as
the Company, the Receiving Agent and the Registrar may reasonably require. Mutilated or defaced Warrant Certificates must be surrendered before replacements will be issued. 

 

	4.	 EXERCISE OF WARRANTS 

 

	4.1	 Subject to this clause 4 and the terms and conditions of this Instrument, a Warrantholder may exercise all or
any portion of its Subscription Rights for all or any whole number of Ordinary Shares for which he is entitled to subscribe at any time during the Subscription Period. The exercise of Subscription Rights must be made subject to, and in
compliance with, any laws and regulations for the time being in force and upon payment of any taxes, duties and other governmental charges payable by reason of the exercise (other than taxes and duties imposed on the Company). Each of the
Registrar and the Receiving Agent shall not have any duty or obligation to take any action under any clause of this Instrument that requires the payment of taxes and/or charges unless and until it is satisfied that all such payments have been made.

  

	4.2	 No fractions of an Ordinary Share will be issued to a Warrantholder upon exercise of any Warrants pursuant to
this Instrument. Where a Warrantholder purports to exercise Warrants for an aggregate amount (a “Purported Exercise Amount”) that is not equal to a multiple of the Minimum Exercise Amount, such purported exercise will only be valid
in respect of the amount of Warrants which are equal to the largest multiple of the Minimum Exercise Amount which is less than the Purported Exercise Amount (the “Largest Multiple Amount”), and the number of Warrants equal to the
Purported Exercise Amount less the Largest Multiple Amount shall lapse and be cancelled, and such Warrantholder will have no further Subscription Rights in respect of such Warrants. 

  
 6 

	4.3	 In order to exercise Subscription Rights, whether in whole or in part, Warrantholders must provide the
Receiving Agent with a Subscription Notice properly completed and duly signed (or any other document(s) as each of the Company and the Receiving Agent may, in its absolute discretion, accept), together with a remittance in cleared funds for the
Exercise Price in respect of the whole number of Ordinary Shares being acquired with respect to the Warrants being exercised. Once so delivered, a Subscription Notice shall be irrevocable save with the consent of the Board. 

 

	4.4	 Warrants will be deemed to be exercised on the Business Day upon which the Receiving Agent (or such other
person as shall have been notified to Warrantholders in accordance with clause 13.2) shall have received the relevant documentation and remittance in cleared funds referred to in this clause 4. Subject to Subscription Rights being validly exercised
and value having been received by the Company in respect of the relevant remittance, and subject to clause 4.7, the Company shall issue the relevant number of Ordinary Shares pursuant to the exercise of Subscription Rights and record the
Warrantholder exercising its right to purchase Ordinary Shares in the Company’s shareholder register of members not later than 10 days after the date on which such Subscription Rights are exercised. If an adjustment is made pursuant to
clause 6 after the exercise date but before the relevant Ordinary Shares have been issued, the Warrantholder will receive such number of Ordinary Shares as it would have received had the exercise taken place following the adjustment taking
effect. 

  

	4.5	 Subject to clause 4.7, as soon as practicable following the exercise of Subscription Rights in accordance with
the terms of this Instrument and, in any event, not later than 28 days after the date on which such Subscription Rights are exercised, the Company shall issue in the event of a partial exercise of Subscription Rights by any Warrantholder, a Warrant
Certificate in the name of such Warrantholder in respect of the balance of the Warrants represented by the relevant Warrant Certificate that remain exercisable. 

 

	4.6	 At any time when the Ordinary Shares are capable of electronic settlement, whether on any securities exchange
or quotation system on which the Ordinary Shares are traded or quoted or otherwise, the Ordinary Shares to be issued upon the exercise of Subscription Rights may, at the absolute discretion of the Board, be issued in any form in such manner as the
Company may notify the Warrantholders, the Registrar and the Receiving Agent. 

  

	4.7	 If demanded by a holder of Warrants upon exercise, the certificate for the Ordinary Shares arising on the
exercise of Warrants (together with any balancing Warrant Certificate) will be dispatched at the risk of the person entitled thereto to the address of such person or (in the case of a joint holding) to that one of them whose name stands first in the
Register or relevant Form of Nomination and will be sent by ordinary postal delivery. 

  

	4.8	 Every Warrant in respect of which Subscription Rights: 

 

	 	4.8.1	 have been exercised in full; or 

 

	 	4.8.2	 have not been exercised (whether in whole or in part) during the Subscription Period, shall lapse and be
cancelled and Warrantholders will have no further Subscription Rights in respect of such Warrants and such Warrants may not be re-issued or re-sold.

  
 7 

	4.9	 Ordinary Shares issued pursuant to the exercise of Warrants in accordance with the terms of this Instrument
shall be issued fully paid and free from any liens, charges or encumbrances and rights of pre-emption but shall not rank for any dividends or other distributions declared, made or paid on the Ordinary Shares
for which the record date is prior to the relevant day on which the Warrants are exercised but, subject thereto, shall rank in full for all dividends and other distributions declared, made or paid on the Ordinary Shares on or after the relevant day
on which the Warrants are exercised and otherwise pari passu in all respects with the Ordinary Shares in issue at that date. 

  

	4.10	 At any time when the Ordinary Shares are listed for trading on the Trading Market and/or any other securities
exchange or quotation system, it is the intention of the Company to apply to Trading Market (or relevant authority for any other securities exchange or quotation system) for the Ordinary Shares issued pursuant to any exercise of Warrants to be
listed for trading on the Trading Market or such other securities exchange or quotation system on which the Ordinary Shares are traded or quoted. 

  

	4.11	 The exercise of Subscription Rights by any holder or beneficial owner of Warrants who is a United States Person
will be subject to such requirements, conditions, restrictions, limitations and/or prohibitions as the Company may at any time impose, in its absolute discretion, for the purpose of complying with the securities laws of the U.S. (including, without
limitation, the Securities Act, the Exchange Act, the U.S. Investment Company Act, and any rules or regulations promulgated under such acts). 

  

	4.12	 The Registrar, the Receiving Agent and the Company reserve the right to delay taking any action on any
particular instructions from the Warrantholder if any of them considers that it needs to do so to obtain further information from the Warrantholder or to comply with any legal or regulatory requirement binding on it (including the obtaining of
evidence of identity to comply with money laundering regulations), or to investigate any concerns they may have about the validity of or any other matter relating to the instruction. 

 

	4.13	 The Company shall not be obliged to issue Ordinary Shares pursuant to the exercise of a Warrant unless
(i) such Ordinary Shares have been registered or qualified or deemed to be exempt under the securities laws of the jurisdiction of state of residence of the Warrantholder, (ii) a registration statement under the Securities Act with respect
to the Ordinary Shares is effective, (iii) the Warrantholder provides the Company with reasonable assurance that such Ordinary Shares can be sold, novated or transferred pursuant to Rule 144 or Rule 144A and the applicable sale of the Ordinary
Shares to be made in reliance on Rule 144 or Rule 144A is made in accordance with the terms thereof (one of which is that a new holding period for the Ordinary Shares issued upon exchange of such Warrants for cash, for purposes of Rule 144 under the
Securities Act, will commence upon issue of such Ordinary Shares) or (iv) in the opinion of legal counsel to the Company, the exercise of the Warrants is exempt from the registration requirements of the Securities Act and such Ordinary Shares
are qualified for sale or exempt from qualification under applicable securities laws of jurisdictions in which the Warrantholder resides. Warrants may not be exercised by, or Ordinary Shares issued or delivered to, any Warrantholder in any state or
other jurisdiction in which such exercise or issue and delivery of Ordinary Shares would be unlawful. 

  
 8 

	4.14	 At any time during the Subscription Period, the Board will have the discretion to refuse to accept a notice of
exercise of Subscription Rights to the extent such exercise may affect the Company’s ability to meet the requirements of the Listing Rules. 

  

	5.	 UNDERTAKINGS 

  

	5.1	 Subject to the provisions of clause 6 and, unless otherwise authorised by a Warrantholder Resolution whilst any
Subscription Rights remain outstanding, the Company shall at all times maintain all requisite board and shareholder or other authorities necessary to enable the issue of Ordinary Shares (free from any rights of
pre-emption) pursuant to the exercise of all the Warrants outstanding from time to time, including a sufficient number of reserved authorized and unissued Ordinary Shares in its Articles.

  

	6.	 ADJUSTMENT OF SUBSCRIPTION RIGHTS 

 

	6.1	 If the Company, at any time while Subscription Rights are outstanding: 

 

	 	6.1.1	 carries out a bonus issue of shares or a share split or a reverse share split; or 

 

	 	6.1.2	 issues any Ordinary Shares by way of dividend or distribution to holders of Ordinary Shares (solely in their
capacity as holders of Ordinary Shares); 

 then in each such case the Exercise Price shall be divided by the quotient of
(x) the number of Ordinary Shares outstanding immediately after such event divided by (y) the number of Ordinary Shares outstanding immediately before such event (the result of such quotient is referred to herein the “Adjustment
Percentage”). Any adjustment made pursuant to clause 6.1.1 or 6.1.2. shall become effective immediately after the record date of such event. Following each adjustment to the Exercise Price pursuant to this clause 6.1, the Portion
shall also be adjusted so that after such adjustment the aggregate Exercise Price payable following adjustment shall be the same as the aggregate Exercise Price in effect immediately prior to such adjustment. 

 

	6.2	 On any adjustment to the Exercise Price pursuant to this clause 6, the resultant Exercise Price, if not an
integral multiple of one cent, will be rounded to the nearest cent (0.5 cents being rounded upwards). 

  

	6.3	 If: 

  

	 	6.3.1	 the Board determines that an adjustment should be made to the Exercise Price and/or the Portion to which each
Warrant relates as a result of one or more events or circumstances not referred to in clause 6.1 or 

  

	 	6.3.2	 an event which gives or may give rise to an adjustment under clause 6.1 occurs in circumstances such that the
Board, in its absolute discretion, determines that the adjustment provisions of clause 6.1 need to be operated subject to some modification in order to give a result which is fair and reasonable in all the circumstances, 

  
 9 

 then the Board may make any adjustment to the Exercise Price and/or Portion or modification
to the operation of clause 6.1 as it determines in good faith to be fair and reasonable to take account of the relevant event or circumstance and upon determination the adjustment (if any) will be made and will take effect in accordance with
the determination. 
 Whenever an adjustment is made or any event affecting the Warrants or their exercisability, the Company shall
(a) promptly prepare a certificate setting forth such adjustment or describing such event, and a brief, reasonably detailed statement of the facts, computation and methodology accounting for such adjustment, and (b) promptly file with the
Receiving Agent. The Receiving Agent shall be fully protected in relying on any such certificate and on any adjustment or statement therein contained and shall have no duty or liability with respect to, and shall not be deemed to have knowledge of
any such adjustment or any such event unless and until it shall have received such certificate. 
  

	7.	 MANDATORY REDEMPTION 

 

	7.1	 Upon the occurrence of the Redemption Event, each Warrant, unless previously exercised or cancelled before the
date set for redemption in accordance with clause 7.3, will be mandatorily redeemed by the Company for US$ 0.01 per Warrant. 

  

	7.2	 The “Redemption Event” occurs if the Average Price of an Ordinary Share for any ten consecutive
Trading Days is equal to or greater than the Redemption Trigger Price (the “Redemption Event”). 

  

	7.3	 The Company will give Warrantholders notice of the Redemption Event having occurred within 20 days of its
occurrence in accordance with the terms of this Instrument and will redeem all Warrants failing to be redeemed on the date set by the Redemption Notice, being a date no longer than 30 days following the occurrence of the Redemption Event. Any
Warrant which is exercised before the date set for redemption by the Redemption Notice will not be redeemed. 

  

	7.4	 On the date set for redemption by the Redemption Notice, the Company shall pay to each holder of Warrants
failing to be redeemed the amount due in respect of such redemption and upon making such payment the relevant Warrant will be cancelled. 

  

	7.5	 If the Board determines that an adjustment should be made to the Redemption Trigger Price as a result of
matters such as any subsequent consolidation or subdivision of the Ordinary Shares or issue of Ordinary Shares to shareholders by way of dividend or distribution, the Board shall determine in good faith as soon as practicable what adjustment (if
any) to the Redemption Trigger Price is fair and reasonable and upon determination the adjustment (if any) will be made and will take effect in accordance with the determination. 

 

	8.	 GENERAL OFFERS AND LIQUIDATION 

 

	8.1	 While any Subscription Rights remain outstanding, if at any time an offer is made to all holders of Ordinary
Shares (or all such holders other than the offeror and/or any company controlled by the offeror and/or persons acting in concert with the offeror) to acquire all or some of the issued Ordinary Shares and the Company becomes aware

  
 10 

	 	
on or before the end of the Subscription Period that as a result of such offer (or as a result of such offer and any other offer made by the offeror) the right to cast a majority of the votes
which may ordinarily be cast on a poll at a general meeting of the Company has or will become vested in the offeror and/or such companies or persons as aforesaid, the Company will give notice to the Warrantholders of such vesting within 14 days
of it occurring, and each such Warrantholder will be entitled, at any time within the period of 30 days immediately following the date of such notice, to exercise his Subscription Rights on the terms on which the same could have been exercised
if they had been exercisable and had been exercised on the date of such notice after which time all Subscription Rights will lapse. If any part of such period falls after the end of the Subscription Period, the end of the Subscription Period will be
deemed to be the last Business Day of that 30-day period. 

  

	8.2	 If the Company enters into liquidation, all Subscription Rights will lapse on the date of the commencement of
the liquidation regardless of the liquidation grounds. 

  

	9.	 TRANSFER AND TITLE 

 

	9.1	 Warrants shall be freely transferable and may be transferred or otherwise disposed of in accordance with this
Instrument and Schedule 2 relating to the transfer, transmission and registration of Warrants shall have full effect as if the same had been incorporated in this Instrument. The Registrar shall
maintain a register of Warrantholders and in accordance with the provisions of Schedule 2. Such Register shall also be available for inspection by the Warrantholders at the registered office of the Company. 

 

	9.2	 The Company shall be entitled to appoint such person or persons as the Company thinks fit as the Registrar and
to remove any such person or persons and make a new appointment in their stead upon 30 days written notice. The Company shall forthwith give a notice of any change in the identity or address of the Registrar in accordance with clause 13.2.

  

	9.3	 The registered holder of a Warrant shall be treated as its absolute owner for all purposes notwithstanding any
notice of ownership or notice of previous loss or theft or of trust or other interest therein (except as ordered by a court of competent jurisdiction or required by law). The Company and the Receiving Agent shall not (except as stated above) be
bound to recognise any other claim to or interest in any Warrant. 

  

	9.4	 Subject to compliance with all applicable laws and regulations for the time being in force, the Company may
make arrangements to enable Warrants to be held in any form in such manner as the Directors may determine from time to time. 

  

	10.	 MEETINGS OF WARRANTHOLDERS 

 

	10.1	 All the provisions of the Articles as to general meetings apply mutatis mutandis to meetings of
Warrantholders, but: 

  

	 	10.1.1	 the necessary quorum is the requisite number of Warrantholders (present in person or by proxy) entitled to
subscribe for two-tenths in number of the Ordinary Shares attributable to such outstanding Warrants; 

  
 11 

	 	10.1.2	 every Warrantholder present in person or by proxy at any such meeting is entitled on a show of hands to one
vote and every such Warrantholder present in person or by proxy is entitled on a poll to one vote for each Ordinary Share for which he is entitled to subscribe; 

 

	 	10.1.3	 any Warrantholder present in person or by proxy may demand or join in demanding a poll; and

  

	 	10.1.4	 if at any adjourned or postponed meeting a quorum as above defined Is not present, the Warrantholder or
Warrantholders then present in person or by proxy are a quorum. 

  

	10.2	 Without prejudice to the generality of the foregoing, the Warrantholders, by way of Warrantholder Resolution,
shall have power to: 

  

	 	10.2.1	 sanction any compromise or arrangement proposed to be made between the Company and the Warrantholders or any of
them; 

  

	 	10.2.2	 sanction any proposal by the Company for modification, abrogation, variation or compromise of, or arrangement
in respect of the rights of the Warrantholders against the Company whether such rights shall arise under this Instrument or otherwise; 

  

	 	10.2.3	 sanction any proposal by the Company for the exchange or substitution for the Warrants of, or the conversion of
the Warrants into, shares, stock, bonds, debentures, debenture stock, warrants or other obligations or securities of the Company or any other body corporate formed or to be formed; 

 

	 	10.2.4	 assent to any modification of the conditions to which the Warrants are subject and/or the provisions contained
in this Instrument which shall be proposed by the Company; 

  

	 	10.2.5	 authorise any person to concur in and execute and do all such documents, acts and things as may be necessary to
carry out and give effect to any Warrantholder Resolution; 

  

	 	10.2.6	 discharge or exonerate any person from any liability in respect of any act or omission for which such person
may have become responsible under this Instrument; and 

  

	 	10.2.7	 give any authority, direction or sanction which under the provisions of this Instrument is required to be given
by Warrantholder Resolution. 

  

	10.3	 A Warrantholder Resolution consented to in writing may be contained in one document or several documents in the
same form, each signed by or on behalf of one or more Warrantholders. 

  
 12 

	11.	 MODIFICATIONS 

 

	11.1	 Any modification to this Instrument and any of the rights attached to the Warrants may be effected only by an
instrument in writing, executed by the Company and the Receiving Agent and expressed to be supplemental to this Instrument and, save in the case of a modification which is of a formal, minor or technical nature or made to correct a manifest error or
a modification deemed necessary or desirable by the Directors in their absolute discretion (acting in good faith) and which the Directors determine in their absolute discretion (acting in good faith) does not adversely affect the interests of
Warrantholders, only if it shall first have been sanctioned by a Warrantholder Resolution of the Warrantholders. Notwithstanding the foregoing, the Company may lower the Exercise Price (permanently or for limited duration) or extend the duration of
the Subscription Period without the prior sanction, consent or approval of Warrantholders. Upon the delivery of a certificate from an authorized officer of the Company which states that the proposed modification is in compliance with the terms of
this clause 11.1, the Receiving Agent shall execute such modification. Notwithstanding anything in this Instrument to the contrary, the Receiving Agent shall not be required to execute any modification to this Instrument that it has determined would
adversely affect its own rights, duties, obligations or immunities under this Instrument. No modification to this Instrument shall be effective unless duly executed by the Receiving Agent. 

 

	11.2	 Notice of every modification to this Instrument shall be given by the Company to the Warrantholders in
accordance with clause 13.2. 

  

	12.	 PURCHASE, SURRENDER AND CANCELLATION 

 

	12.1	 The Company may at any time purchase, from one or more Warrantholders, Warrants, whether:

  

	 	12.1.1	 by tender at any price; or 

 

	 	12.1.2	 on or through the market; or 

 

	 	12.1.3	 by private treaty at any price, 

or otherwise, on such terms as the Directors, in their absolute discretion, (acting in good faith) determine provided such purchases are made
in accordance with applicable laws and regulations and the rules of any stock exchange or trading platform on which Warrants are listed or traded. 
  

	12.2	 The Company shall accept the surrender (for no consideration) of Warrants at any time. 

 

	12.3	 All Warrants purchased pursuant to clause 12.1 or surrendered shall be cancelled forthwith and may not be
reissued or sold. 

  

	13.	 AVAILABILITY OF INSTRUMENT AND NOTICES 

 

	13.1	 Every Warrantholder shall be entitled to inspect a copy of this Instrument at (i) the registered office of
the Company or (ii) the offices of the Receiving Agent designated for such purposes (which initially shall be 150 Royall Street, Canton, Massachusetts, 02021, USA) or (iii) such other address as the Receiving Agent may appoint) during
normal business hours (Saturdays, Sundays and public holidays in the location of the Receiving Agent excepted), and shall be entitled to receive a copy of this Instrument against payment of such charges as the Board may impose in its absolute
discretion. 

  
 13 

	13.2	 Notices to be given pursuant to the provisions of this Instrument shall be given in accordance with Schedule 2,
paragraph 4. 

  

	13.3	 The Company will use reasonable endeavours to give written notice to each Warrantholder at least fifteen
calendar days prior to the date on which the Company closes its books or takes a record (A) with respect to any distribution on the Ordinary Shares or (B) for determining rights to vote with respect to any voluntary dissolution or
voluntary liquidation of the Company. 

  

	14.	 PURCHASE OF ORDINARY SHARES BY THE COMPANY 

The Company may at any time purchase Ordinary Shares, or arrange for the purchase of Ordinary Shares on its behalf or by any other member of
its group, without requiring the consent of Warrantholders for such purchase. 
  

	15.	 ENFORCEMENT 

  

	15.1	 The Company acknowledges and covenants that the benefit of the covenants, obligations and conditions on the
part of or binding upon it contained in this Instrument and the schedules hereto shall enure to the benefit of each and every Warrantholder and the Registrar and Receiving Agent and each of its successors and assigns. 

 

	15.2	 Each Warrantholder shall be entitled to enforce the said covenants, obligations and conditions against the
Company insofar as such Warrantholder’s Warrant is concerned, without the need to join the allottee of any such Warrant or any intervening or other Warrantholder in the proceedings for such enforcement. 

 

	16.	 GOVERNING LAW 

 

	16.1	 This Instrument shall be governed by the laws of the Grand Duchy of Luxembourg without regard to its rules on
conflict of laws, except that the rights, immunities, duties and obligations of the Warrant Agent shall be governed by and construed in accordance with the laws of the State of Delaware applicable to contracts made and to be performed entirely
within such state without regard to its rules of conflict of laws. 

  

	16.2	 The courts of the Grand Duchy of Luxembourg shall have exclusive jurisdiction to settle any dispute or claim
arising out of or in connection with this Instrument or any Warrant or their subject matter or formation (including non-contractual disputes or claims). Notwithstanding the foregoing, each party
(i) agrees that the courts of the State of Delaware and of the United States of America located in such state (the “Delaware Courts”) shall have exclusive jurisdiction to settle any dispute or claim to which the Warrant Agent is
party, (ii) agrees that it will not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from the Delaware Courts, and (iii) waives any claim of improper venue or any claim that the Delaware Courts are
an inconvenient forum. 

  
 14 

	17.	 SEVERABILITY 

  

	17.1	 If any term, provision, covenant or restriction of this Instrument is held by a court of competent jurisdiction
or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Instrument shall remain in full force and effect and shall in no way be affected, impaired or invalidated; provided,
however, that if such excluded provision shall affect the rights, immunities, liabilities, duties or obligations of the Receiving Agent, the Receiving Agent shall be entitled to resign immediately upon written notice to the Company.

  

	18.	 FORCE MAJEURE 

 

	18.1	 Notwithstanding anything to the contrary contained herein, the Receiving Agent shall not be liable for any
delays or failures in performance resulting from acts beyond its reasonable control including, without limitation, acts of God, epidemics, pandemics, terrorist acts, shortage of supply, breakdowns or malfunctions, interruptions or malfunctions of
any utilities, communications, or computer facilities, or loss of data due to power failures or mechanical difficulties with information storage or retrieval systems, labor difficulties, war or civil unrest. 

 

	19.	 CONCERNING THE RECEIVING AGENT 

 

	19.1	 The rights, duties and immunities of the Receiving Agent are set forth on Schedule 3 attached hereto and
incorporated herein by reference. The parties hereto acknowledge and agree that all references to the Receiving Agent shall include Computershare Inc. in its capacity as Registrar, as applicable. 

[Signature Page Follows] 

  
 15 

 This Instrument has been executed by the Company and Computershare Inc. on the date first
written above. 
  

	
	 PERIMETER SOLUTIONS SA

	
	 /s/ Haitham Khouri

	 Name: Haitham Khouri

	 Title: Director

	
	 COMPUTERSHARE TRUST COMPANY,

	 N.A. and COMPUTERSHARE INC.

	 On behalf of both entities

	
	 /s/ Collin Ekeogu

	 Name: Collin Ekeogu

	 Title: Manager, Corporate Actions

  
 16 

 SCHEDULE 1 

FORM OF WARRANT CERTIFICATE 
 THE
SECURITIES REPRESENTED BY THIS WARRANT CERTIFICATE (INCLUDING THE SECURITIES ISSUABLE UPON EXERCISE OF ANY WARRANT) MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR NOVATED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR
THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR (B) AN OPINION OF COUNSEL TO THE HOLDER (IF REQUESTED BY THE COMPANY), IN A FORM REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER THE ACT. 
 THE SECURITIES REPRESENTED BY THIS WARRANT CERTIFICATE
(INCLUDING THE SECURITIES ISSUABLE UPON THE EXERCISE OF ANY WARRANT) ARE SUBJECT TO THE TERMS AND CONDITIONS SET FORTH IN THE WARRANT INSTRUMENT DATED NOVEMBER 8th , 2021, EXECUTED BY THE
COMPANY (AS MODIFIED, SUPPLEMENTED, AMENDED OR AMENDED AND RESTATED FROM TIME TO TIME, THE “WARRANT INSTRUMENT”). COPIES OF SUCH INSTRUMENT MAY BE OBTAINED BY THE HOLDER HEREOF AT (I) THE REGISTERED OFFICE OF PERIMETER
SOLUTIONS SA AT THE ADDRESS BELOW AND/OR (II) THE OFFICES OF THE REGISTRAR’S AGENT, WHO INITIALLY IS COMPUTERSHARE INC., AT THE ADDRESS BELOW (OR SUCH OTHER PLACE AS THE COMPANY OR THE REGISTRAR MAY APPOINT). 

SEE ANNEX A TO THIS WARRANT CERTIFICATE FOR ADDITIONAL RESTRICTIVE LEGENDS APPLICABLE TO THIS WARRANT 

 

			
	 No. of Certificate:
	  	 [•]

		
	 Number of Warrants:
	  	 [•]

		
	 Date of issue:
	  	 [•]

 Warrants to subscribe for ordinary share(s) in 

Perimeter Solutions SA 

Registered Office: 12E, rue Guillaume Kroll, L-1882 Luxembourg, Grand Duchy 

of Luxembourg incorporated in the Grand Duchy of Luxembourg 

  
 17 

 This is to evidence that [•] of [•] is/are the registered holder(s) of [•] Warrants in
Perimeter Solutions SA issued pursuant to and in accordance with the terms of the Warrant Instrument (as from time to time amended) executed by Perimeter Solutions SA and the Receiving Agent thereunder. Words and expressions used in this Warrant
Certificate and the Subscription Notice shall have the same meanings as in the Warrant Instrument. 
 The registered holder is entitled in respect of every
one Warrant held to subscribe for the applicable Portion of an Ordinary Share during the Subscription Period on the terms and conditions set forth in the Warrant Instrument. At the date of issue of this certificate, the applicable Portion is
[one-fourth][insert applicable Portion if there has been a prior adjustment] of an Ordinary Share. 
 Warrants are exercisable only as specified in clause 4
of the Warrant Instrument. 
 The Warrant Instrument is enforceable severally by each Warrantholder and is available for inspection at (i) the
registered office of Perimeter Solutions SA (mentioned above) and the offices of the Receiving Agent designated for such purposes (which initially shall be at 150 Royal Street, Canton, Massachusetts, 02021, USA) or such other Registrar’s agent
and address as the Registrar may appoint until the end of the Subscription Period. 
 Executed by the Company on [•], 2021. 

This Warrant Certificate is subject to all of the terms, provisions and conditions of the Warrant Instrument, which terms, provisions and conditions are
hereby incorporated herein by reference and made a part hereof and to which Warrant Instrument reference is hereby made for a full description of the rights, limitations of rights, obligations, duties and immunities hereunder of the Company, the
Receiving Agent and the holders of the Warrant Certificates. 
  

	
	 PERIMETER SOLUTIONS SA

	
	 
	 Name:

	 Title:

	
	 COMPUTERSHARE TRUST COMPANY,

	 N.A. and COMPUTERSHARE INC.

	 On behalf of both entities

	
	 
	 Name:

	 Title:

  
 18 

 Annex A 

PRIOR TO INVESTING IN THE SECURITIES OR CONDUCTING ANY TRANSACTIONS IN THE SECURITIES, INVESTORS ARE ADVISED TO CONSULT PROFESSIONAL ADVISERS REGARDING THE
RESTRICTIONS ON TRANSFER SUMMARIZED BELOW AND ANY OTHER RESTRICTIONS. 
 SUBSCRIPTION NOTICE 

In order to exercise all or any of the Warrants represented by this Warrant Certificate, this Subscription Notice duly completed and signed, together with the
payment in cleared funds referred to below, must be submitted to the Registrar’s Receiving Agent, who is initially Computershare Inc. located at 150 Royal Street, Canton, Massachusetts, 02021, USA (or such other Receiving Agent and address as
the Registrar may appoint). 
 To: The Directors, Perimeter Solutions SA 

I/We the undersigned, being the registered holder(s) of the [•] Warrants hereby give(s) notice of his/their wish to exercise [•] Warrant(s) to
subscribe for [•] Ordinary Shares in Perimeter Solutions SA in accordance with the provisions of the Warrant Instrument. 
 I/We enclose payment for
US$ [•] in favour of Perimeter Solutions SA being the aggregate payment of the full subscription price for the total number of such Warrants.* 
  

	*	 Please contact the Receiving Agent if you wish to pay by way of electronic transfer. 

I/We direct you to issue the relevant number of Ordinary Shares to the person(s) whose name(s) and address(es) is/are set out in the Form of Nomination set
out below and who has signed the acceptance set out therein or, if none is set out, to me/us in which event I/we agree to accept such shares subject to the Articles of Association of Perimeter Solutions SA. 

I/We authorise and request the entry of the name(s) of such persons in the register of shareholders of the Company in respect thereof. 

I/We require the dispatch of 
  

	(a)	 certificates in respect of the Ordinary Share(s) to be issued to such Persons; and 

 

	(b)	 a Warrant Certificate in the name(s) of such persons for any balance of my/our Warrants remaining exercisable,

 at the risk of such persons to such address as is set out in the Form of Nomination or, if none is set out, to my/our address set out
in the Register of Warrantholders or (in the case of joint holders) to the address of that one whose name stands first in such form of Nomination or (if applicable) Register in respect of the Warrants represented by this Warrant Certificate by
ordinary postal service. 
  

			
	
		
	Dated:	 	 
		
	Signature(s):	 	 
		
		 	 

  
 19 

 GUIDANCE NOTES: 

Exercise of the Warrants represented by this Warrant Certificate may be consolidated with the exercise of Warrants represented by other Warrant Certificates by
the use of only one Subscription Notice, provided that the other Warrant Certificates are attached to the Subscription Notice. 
 In the case of joint
holdings, all joint holders must sign. 

  
 20 

 FORM OF NOMINATION 

Please insert in BLOCK CAPITALS in the box below the full name(s) of the person(s) to whom you wish the Ordinary Share(s) arising on the exercise of
your Warrants to be issued and the address to which any certificate for such Ordinary Share(s) together with any balance certificate for Warrants should be sent and the address of the sole or first-named Warrantholder. 

I/We agree to accept all the fully paid Ordinary Shares of the Company to be issued to me/us subject to the Articles of Association of
Perimeter Solutions SA. 
 Signed _______________________________ 

Dated ________________________________ 
 If the
above box is left blank, the Ordinary Shares will be issued to the Warrantholder(s) named in the relevant Warrant Certificate and the certificate for such Ordinary Shares together with any balance Warrant Certificate will be sent to the registered
address of the sole or first-named Warrantholder. 

  
 21 

 SCHEDULE 2 

REGISTRATION, TRANSFER AND TRANSMISSION 
  

	1.	 REGISTRATION AND TITLE 

 

	1.1	 An accurate register of the Warrants (the “Register”) will be kept by the Registrar and there
shall be entered in the Register: 

  

	 	1.1.1	 the names and addresses of the Warrantholders; 

 

	 	1.1.2	 the amount of Warrants held by every registered holder; and 

 

	 	1.1.3	 the date upon which the name of every such registered holder is entered in respect of the Warrants standing in
his name. 

  

	1.2	 Any change of name or address on the part of a Warrantholder shall forthwith be notified to the Registrar at
the office of its agent, who is initially Computershare Inc. with offices at 150 Royall Street, Canton, Massachusetts, 02021, USA (or such other place as the Registrar may appoint), who shall cause the Register to be altered accordingly. The
Register may be closed by the Company for such period or periods and at such times as it may think fit provided that it shall not be closed for more than thirty days in any calendar year. Any transfer made while the Register is so closed shall, as
between the Company and the person claiming under the transfer (but not otherwise), be considered as made immediately after the reopening of the Register. The Warrantholders or any of them, and any person duly authorised by any such holder, shall be
at liberty at all reasonable times during office hours to inspect the Register and to take copies of or extracts from the same or any part thereof. 

  

	1.3	 The Company, the Registrar and the Receiving Agent shall be entitled to treat the registered holder of any
Warrant as the absolute owner thereof for all purposes notwithstanding any notice of ownership or writing thereon or notice of previous loss or theft or of trust (whether express or implied) or other interest therein (except as ordered by a court of
competent jurisdiction or required by law) and shall not (except as aforesaid) be bound to recognise any equitable or other claim to or interest in such Warrant. 

 

	1.4	 Every Warrantholder will be recognised by the Company as entitled to his Warrants free from any equity, set-off or cross-claim on the part of the Company against the original or any intermediate holder of the Warrants. 

  

	1.5	 Such Register shall also be available for inspection by the Warrantholder at the registered office of the
Company. 

  

	2.	 TRANSFER 

  

	2.1	 Warrants shall be freely transferable in accordance with the Instrument. The instrument of transfer of a
Warrant shall be signed by or on behalf of the transferor and by or on behalf of the transferee. Entry in the Register of a transferee’s name and/or details of Warrants transferred shall be the Company’s and transferor’s agreement in
respect of each novation and upon registration all the rights of the transferor in respect of Warrants transferred shall cease. In consideration of (inter  

  
 22 

	 	
alia) the transferee agreeing to be registered as the holder of Warrants the Company shall assume such obligations towards the transferee and the transferee shall have such rights in
respect of such Warrants as are set out under the terms of this Instrument. The transferor shall be deemed to remain the holder of the Warrant until the name of the transferee is entered in the Register in respect thereof. The Company shall not be
obliged to give effect to any such instrument which purports to transfer any Warrants in respect of which a Subscription Notice shall have been received. 

  

	2.2	 The Company may decline to recognise any instrument of transfer unless such instrument is properly completed
and deposited at the office of the Receiving Agent designated for such purposes (which initially shall be 150 Royall Street, Canton, Massachusetts, 02021, USA) (or such other place as the Registrar may appoint), accompanied by a signature guarantee,
and such other evidence as the Registrar or Receiving Agent may reasonably require to show the right of the transferor to make the transfer and, if the instrument of transfer is executed by some other person on behalf of the transferor, the
authority of that person so to do. The Registrar or Receiving Agent may waive production of any Warrant Certificate upon evidence satisfactory to the Registrar or Receiving Agent of its loss or destruction or upon execution of an appropriate
indemnity reasonably satisfactory to the Registrar and the Receiving Agent. All instruments of transfer which are registered may be retained by the Company for so long as it thinks fit together with the cancelled Warrant Certificates.

  

	2.3	 No fee shall be charged by the Company in respect of the registration of any instrument of transfer or probate
or letters of administration or certificate of marriage or death, or power of attorney or other document relating to or affecting the title to any Warrants or otherwise for making any entry in the Register affecting the title to any Warrants.

  

	2.4	 The registration of a transfer shall be conclusive evidence of the approval by the Company and the Registrar of
the transfer and the Company shall, on registration, issue the transferee with a Warrant Certificate in respect of the Warrants transferred. 

  

	3.	 TRANSMISSION 

  

	3.1	 In the case of the death of a Warrantholder the survivors or survivor where the deceased was a joint holder,
and the executors or administrators of the deceased where he was a sole or only surviving holder, shall be the only persons recognised by the Company and the Registrar as having any title to his Warrants, but nothing herein contained shall release
the estate of a deceased Warrantholder (whether sole or joint) from any liability in respect of any Warrant solely or jointly held by him. 

  

	3.2	 Subject to any other provision herein contained, any person becoming entitled to a Warrant in consequence of
the death or bankruptcy of a Warrantholder or otherwise than by transfer may, upon producing such evidence of title as the Company shall reasonably require, and subject as hereinafter provided, be registered himself as holder of the Warrant.

  
 23 

	3.3	 Subject to any other provision herein contained, if any person becoming entitled to a Warrant in consequence of
the death or bankruptcy of a Warrantholder or otherwise than by transfer shall elect to be registered himself, he shall deliver or send to the Company and the Receiving Agent designated for such purposes (which initially shall be 150 Royall Street,
Canton, Massachusetts, 02021, USA) (or such other place as the Registrar may appoint), a notice in writing signed by him stating that he so elects. All the limitations, restrictions and provisions herein contained relating to the right to transfer
and the registration of transfers of Warrants shall be applicable to any such notice of transfer as aforesaid as if the death or bankruptcy of the Warrantholder had not occurred and the notice of transfer were a transfer executed by such
Warrantholder. 

  

	3.4	 A person becoming entitled to a Warrant in consequence of the death or bankruptcy of a Warrantholder shall be
entitled to receive and may give good discharge for any monies payable in respect thereof, but shall not be entitled to receive notices of or to attend or vote at meetings of the Warrantholders or, save as aforesaid, to any of the rights or
privileges of a Warrantholder until he shall have become a Warrantholder in respect of the Warrant. 

  

	4.	 NOTICES 

  

	4.1	 Every Warrantholder shall register with the Company and the Registrar an address to which copies of notices can
be sent. Any notice or document may be given or served by the Company, Registrar or Receiving Agent on any Warrantholder either personally or by sending it by post in a prepaid letter addressed to such Warrantholder at his registered address as
appearing in the register or by facsimile transmission to any facsimile number notified by such Warrantholder to the Company. 

  

	4.2	 Notices or demands authorized by this Instrument to be given by the Receiving Agent or Warrantholder to the
Company shall be sufficiently given if sent in writing by post prepaid and addressed (until another address is filed in writing with the Receiving Agent) as follows: 

c/o Perimeter Solutions SA 
 12E,
rue Guillaume Kroll 
 L-1882 Luxembourg 

Grand Duchy of Luxembourg 
  

	4.3	 Any notice or demand authorized by this Instrument to be given by the Company or by a Warrantholder to the
Receiving Agent shall be sufficiently given if sent in writing by first class post, prepaid and addressed (until another address is filed in writing with the Company) as follows: 

Computershare Inc. 
 150 Royall
Street 
 Canton, Massachusetts 02021 

USA 
 Attention: Client Services

  

	4.4	 Any notices given pursuant to the provisions of this schedule with respect to Warrants standing in the names of
joint holders shall be given to whichever of such persons is named first in the Register and such notice so given shall be sufficient notice to all the holders of such Warrants. 

  
 24 

	4.5	 Proof that an envelope containing a notice was properly addressed, prepaid and posted shall be conclusive
evidence that the notice was given. A notice shall be deemed to be given at the expiration of forty-eight hours after the envelope containing it was posted. Any notice given by facsimile transmission shall be deemed to have been served at the time
of transmission by the sender in the absence of an indication of failure of transmission when transmitted. 

  

	4.6	 When a given number of days’ notice or notice extending over any other period is required to be given, the
day of service shall, but the day upon which such notice shall expire shall not, be included in calculating such number of days or other period. The signature to any notice to be given by the Company may be written or printed. 

 

	4.7	 Every person who by operation of law, transfer or other means whatsoever becomes entitled to a Warrant shall be
bound by any notice in respect of such Warrant which, before his name is entered in the Register, has been duly given to the person from whom he derives his title. 

 

	4.8	 If at any time by reason of the suspension or curtailment of postal services the Company is unable effectively
to convene a meeting of the Warrantholders by notices sent through the post, such a meeting may be convened by a notice advertised in at least two national daily newspapers with appropriate circulations (and, where there is a suspension or
curtailment of postal services within (i) the Grand Duchy of Luxembourg, at least one of which shall be published in Luxembourg or (ii) the United States, at least one of which shall be published in New York City) and such notice shall be
deemed to have been duly served on all Warrantholders entitled thereto at noon on the day when the advertisement appears. In any such case the Company shall send confirmatory copies of the notice by post if prior to the meeting the posting of
notices to addresses again becomes practicable. 

  

	4.9	 Any Warrantholder present, either personally or by proxy, at any meeting of the Warrantholders shall for all
purposes be deemed to have received due notice of such meeting, and, where requisite, of the purposes for which such meeting was called. 

  

	4.10	 Any notice or document delivered or sent by post to or left at the registered address of any Warrantholder or
sent by facsimile transmission to any facsimile number notified by such Warrantholder to the Company in pursuance of this Instrument shall, notwithstanding that such Warrantholder is then dead, bankrupt, of unsound mind or (being a corporation) in
liquidation, and whether or not the Company has notice of the death, bankruptcy, insanity or liquidation of such Warrantholder, be deemed to have been duly served in respect of any Warrant registered in the name of such Warrantholder as sole or
joint holder unless his name has at the time of the service of the notice or document been removed from the Register as the holder of the Warrant, and such service shall for all purposes be deemed a sufficient service of such notice or document on
all persons interested (whether jointly with or as claiming through or under him) in the Warrant. 

  
 25 

	5.	 PAYMENT OF REDEMPTION OR OTHER MONEYS 

Any redemption amount or other moneys payable to a Warrantholder may be paid by electronic transfer or cheque sent by post to the registered
address of the person entitled or, if two or more persons are the holders of the Warrant or are jointly entitled to it by reason of the death or bankruptcy of the holder, to the registered address of the one of those persons who is first named in
the Register or to such person and to such address as the person or persons entitled may in writing direct (and in default of such direction to that one of the persons jointly so entitled as the Directors shall in their absolute discretion
determine). Every cheque shall be made payable to the order of the person or persons entitled or to such other person as the person or persons entitled may in writing direct and payment of the cheque shall be a good discharge to the Company. Any
joint holder or other person jointly entitled to a Warrant as aforesaid may give receipts for any dividend or other moneys payable in respect of the Warrant. Every cheque is sent at the risk of the person entitled to the payment. If payment is made
by electronic transfer, the Company is not responsible for amounts lost or delayed in the course of making that payment. 

  
 26 

 SCHEDULE 3 

CONCERNING THE RIGHTS AGENT; MERGER, CONSOLIDATION OR 

CHANGE OF RECEIVING AGENT 
  

	1.	 CONCERNING THE RECEIVING AGENT 

 

	1.1	 As mutually agreed between the Company and the Receiving Agent in a fee schedule to be executed on or about the
date hereof, the Company agrees to pay to the Receiving Agent compensation for all services rendered by it hereunder, and, from time to time, on demand of the Receiving Agent, its reasonable expenses and counsel fees and other disbursements incurred
in the preparation, negotiation, delivery, amendment, administration and execution of this Instrument and the exercise and performance of its duties hereunder. The Company also agrees to indemnify the Receiving Agent (including employees, directors,
officers and agents of the Receiving Agent) for, and to hold it harmless against, any loss, liability, damage, judgment, fine, penalty, claim, demand, settlement or expense (including the reasonable fees and expenses of legal counsel) that may be
paid, incurred or suffered by it, or which it may become subject, without gross negligence, bad faith or willful misconduct on the part of the Receiving Agent (which gross negligence, bad faith or willful misconduct must be each as determined by a
final, non-appealable judgment of a court of competent jurisdiction) for any action taken, suffered or omitted to be taken by the Receiving Agent (including employees, directors, officers and agents of the
Receiving Agent), for anything done or omitted by the Receiving Agent in connection with the acceptance, administration, exercise and performance of its duties under this Instrument, including the costs and expenses of defending against any claim of
liability in connection herewith. The reasonable costs and expenses incurred in enforcing this right of indemnification shall be paid by the Company. 

The Receiving Agent shall be fully authorized and protected and shall incur no liability for, or in respect of any action taken, suffered or
omitted by it in connection with, its acceptance and administration of this Instrument and the exercise and performance of its duties hereunder, in reliance upon any Warrant Certificate or certificate for other securities of the Company (including
in the case of uncertificated securities, by notation in book entry accounts reflecting ownership), instrument of assignment or transfer, power of attorney, endorsement, affidavit, letter, notice, instruction, direction, consent, certificate,
statement, or other paper or document believed by it to be genuine and to be signed, executed and, where necessary, verified or acknowledged, by the proper Persons, or otherwise upon the advice of counsel. 

Notwithstanding anything in this Instrument to the contrary, in no event will the Receiving Agent be liable for special, punitive, indirect,
incidental or consequential loss or damage of any kind whatsoever (including but not limited to lost profits), even if the Receiving Agent has been advised of the likelihood of such loss or damage and regardless of the form of action. The Receiving
Agent shall not be deemed to have knowledge of any event of which it was supposed to receive notice thereof hereunder, and the Receiving Agent shall be fully protected and shall incur no liability for failing to take any action in connection
therewith, unless and until it has received such notice in writing, and all notices or other instruments required by this Instrument to be delivered to the Receiving Agent must, in order to be effective, be received by the Receiving Agent as
specified in clause 4.3 of Schedule 2. The provisions of this clause 1.1 shall survive the termination of this Instrument, the exercise or expiration of the Warrants and the resignation, replacement or removal of the Receiving Agent. 

  
 27 

	2.	 MERGER OR CONSOLIDATION OR CHANGE OF NAME OF RECEIVING AGENT 

 

	2.1	 Any Person into which the Receiving Agent or any successor Receiving Agent may be merged or with which it may
effect a share exchange, be consolidated, or otherwise combined, or any Person resulting from any merger, share exchange, consolidation, or combination to which the Receiving Agent or any successor Receiving Agent shall be a party, or any Person
succeeding to the stock transfer or other shareholder services of the Receiving Agent or any successor Receiving Agent, shall be the successor to the Receiving Agent under this Instrument without the execution or filing of any paper or document or
any further act on the part of any of the parties hereto; provided that such Person would be eligible for appointment as a successor Receiving Agent under the provisions of this Instrument. The purchase of all or substantially all of the Receiving
Agent’s assets employed in the performance of transfer agent activities shall be deemed a merger or consolidation for purposes of this clause 2.1. In case at the time such successor Receiving Agent shall succeed to the agency created by this
Instrument, any of the Warrant Certificates shall have been countersigned but not delivered, any such successor Receiving Agent may adopt the countersignature of the predecessor Receiving Agent and deliver such Warrant Certificates so countersigned;
and, in case at that time any of the Warrant Certificates shall not have been countersigned, any successor Receiving Agent may countersign such Warrant Certificates either in the name of the predecessor Receiving Agent or in the name of the
successor Receiving Agent; and, in all such cases, such Warrant Certificates shall have the full force provided in the Warrant Certificates and in this Instrument. In case at any time the name of the Receiving Agent shall be changed and at such time
any of the Warrant Certificates shall have been countersigned but not delivered, the Receiving Agent may adopt the countersignature under its prior name and deliver Warrant Certificates so countersigned; and, in case at that time any of the Warrant
Certificates shall not have been countersigned, the Receiving Agent may countersign such Warrant Certificates either in its prior name or in its changed name; and, in all such cases, such Warrant Certificates shall have the full force provided in
the Warrant Certificates and in this Instrument. 

  

	3.	 RIGHTS AND DUTIES OF RECEIVING AGENT 

 

	3.1	 The Receiving Agent undertakes to perform only the duties and obligations expressly set forth in this
Instrument and no implied duties or obligations shall be read into this Instrument against the Receiving Agent. The Receiving Agent shall perform those duties and obligations upon the following terms and conditions, by all of which the Company and
the Warrantholders, by their acceptance thereof, shall be bound: 

  

	 	3.1.1	 The Receiving Agent may consult with legal counsel selected by it (who may be legal counsel for the Company or
an employee or legal counsel of the Receiving Agent), and the advice or opinion of such counsel shall be full and complete authorization and protection to the Receiving Agent and the Receiving Agent shall incur no liability for or in respect of any
action taken, suffered or omitted to be taken by it in accordance with such advice or opinion. Whenever in the performance of its duties under this Instrument the 

  
 28 

	 	
Receiving Agent shall deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless
other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a certificate signed by any authorized officer of the Company and delivered to the Receiving Agent; and such certificate
shall be full and complete authorization and protection to the Receiving Agent and the Receiving Agent shall incur no liability for or in respect of any action taken, suffered, or omitted to be taken, in each case, in the absence of bad faith, by it
under the provisions of this Instrument in reliance upon such a certificate. The Receiving Agent shall have no duty to act without such a certificate as set forth in this clause 3.1.1. 

 

	 	3.1.2	 The Receiving Agent shall be liable hereunder to the Company and any other Person only for its own gross
negligence, bad faith or willful misconduct (which gross negligence, bad faith or willful misconduct must be determined by a final, non-appealable judgment of a court of competent jurisdiction). Any liability
of the Receiving Agent under this Instrument shall be limited to the amount of the annual fees paid (excluding reimbursed charges and expenses) by the Company to the Receiving Agent during the twelve (12) months immediately preceding the event
for which recovery from the Receiving Agent is being sought. The Receiving Agent shall not be liable for or by reason of any of the statements of fact or recitals contained in this Instrument or in the Warrant Certificates (except its
countersignature thereof) or be required to verify the same, but all such statements and recitals are and shall be deemed to have been made by the Company only. 

 

	 	3.1.3	 The Receiving Agent shall not have any liability or be under any responsibility in respect of the validity of
this Instrument or the execution and delivery hereof (except the due execution hereof by the Receiving Agent) or in respect of the legality or validity or execution of any Warrant Certificate (except its countersignature thereof); nor shall it be
responsible for any breach by the Company of any covenant or failure by the Company to satisfy any condition contained in this Instrument or in any Warrant Certificate; nor shall it be liable or responsible for modification by or order of any court,
tribunal, or governmental authority in connection with the foregoing, any change in the exercisability of the Warrants or any adjustment in the terms of the Warrants (including but not limited to the manner, method or amount thereof) provided for in
this Instrument, or responsible for the manner, method or amount of any such adjustment or the ascertaining of the existence of facts that would require any such change or adjustment (except with respect to the exercise of Warrants evidenced by
Warrant Certificates after receipt of a certificate furnished pursuant to this Instrument describing such change or adjustment upon which the Receiving Agent may rely); nor shall it by any act hereunder be deemed to make any representation or
warranty as to the authorization or reservation of any Ordinary Shares or other securities to be issued pursuant to this Instrument or any Warrant Certificate or as to whether any Ordinary Shares or other securities will, when so issued, be validly
authorized and issued, fully paid and nonassessable. The Company agrees that it will perform, execute, acknowledge and deliver or cause to be performed, executed, acknowledged and delivered all such further and other acts, instruments and assurances
as may reasonably be required by the Receiving Agent for the carrying out or performing by the Receiving Agent of the provisions of this Instrument. 

  
 29 

	 	3.1.4	 The Receiving Agent is hereby authorized and directed to accept written instructions with respect to the
performance of its duties hereunder and certificates delivered pursuant to any provision hereof from any Person reasonably believe by the Receiving Agent to be one of the authorized officers of the Company, and to apply to such officers for advice
or instructions in connection with its duties under this Instrument, and such advice or instructions shall provide full authorization and protection to the Receiving Agent, and it shall not be liable for any action taken or suffered by it in
accordance with the written advice or instructions of any such officer or for any delay in acting while waiting for those instructions. The Receiving Agent shall be fully authorized and protected in relying upon the most recent advice or
instructions received in writing from any such officer. Any application by the Receiving Agent for written instructions from the Company may, at the option of the Receiving Agent, set forth in writing any action proposed to be taken, suffered or
omitted to be taken by the Receiving Agent with respect to its duties and obligations under this Instrument and the date on and/or after which such action shall be taken, suffered or such omission shall be effective. The Receiving Agent and any
stockholder, affiliate, member, director, officer, agent, representative, or employee of the Receiving Agent may buy, sell or deal in any of the Warrants or other securities of the Company or become pecuniarily interested in any transaction in which
the Company may be interested, or contract with or lend money to the Company or otherwise act as fully and freely as though it were not the Receiving Agent under this Instrument. Nothing herein shall preclude the Receiving Agent or any such
stockholder, affiliate, director, member, officer, agent, representative or employee from acting in any other capacity for the Company or for any other Person. 

 

	 	3.1.5	 The Receiving Agent may execute and exercise any of the rights or powers hereby vested in it or perform any
duty hereunder either itself (through its directors, officers and employees) or by or through its attorneys or agents, and the Receiving Agent shall not be answerable or accountable for any act, omission, default, neglect or misconduct of any such
attorneys or agents or for any loss to the Company, to the holders of the Warrants or any other Person, resulting from any such act, omission, default, neglect or misconduct, absent gross negligence or bad faith in the selection and continued
employment thereof (which gross negligence or bad faith must be determined by a final, non-appealable judgment of a court of competent jurisdiction).No provision of this Instrument shall require the Receiving
Agent to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or in the exercise any of its rights or powers if it believes that repayment of such funds or adequate indemnification
against such risk or liability is not reasonably assured to it. 

  
 30 

	 	3.1.6	 The Receiving Agent shall have no responsibility to the Company, any Warrantholders or any holders of Common
Shares for interest or earnings on any monies held by the Receiving Agent pursuant to this Instrument. 

  

	4.	 CHANGE OF RECEIVING AGENT 

The Receiving Agent or any successor Receiving Agent may resign and be discharged from its duties under this Instrument upon 30 days’
notice in writing posted to the Company. In the event the transfer agency relationship in effect between the Company and the Receiving Agent terminates, the Receiving Agent will be deemed to have resigned automatically and be discharged from its
duties as Receiving Agent under this Instrument as of the effective date of such termination, and the Company shall be responsible for sending any required notice. The Company may remove the Receiving Agent or any successor Receiving Agent (with or
without cause) upon 30 days’ notice in writing, posted to the Receiving Agent or successor Receiving Agent, as the case may be, and to each transfer agent of the Ordinary Shares by registered or certified post, and to the holders of the
Warrant Certificates by first-class post. If the Receiving Agent shall resign or be removed or shall otherwise become incapable of acting, the Company or the Registrar shall appoint a successor to the Receiving Agent. 

  
 31EX-10.13

 Exhibit 10.13 

PERIMETER SOLUTIONS S.A. 

2021 EQUITY INCENTIVE PLAN 
 1.
Purpose and Duration 
 1.1 Purpose. The purpose of the Plan is to promote the interests of the Company and its stockholders by:
(i) providing a means for the Company and its Affiliates to attract and retain employees, officers, consultants, advisors, and directors who will contribute to the Company’s long-term growth and success; and (ii) providing such
individuals with incentives that will align the interests of such individuals with those of the stockholders of the Company. Incentives available under this Plan include Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights,
Restricted Stock, Restricted Stock Units, Performance Shares, Performance Share Units, and Other Awards. 
 1.2 Duration. The Plan shall
commence on the Effective Date and shall remain in effect, subject to the right of the Board of Directors to amend or terminate the Plan at any time pursuant to Section 13, until all Shares subject to the Plan shall have been issued according
to the Plan’s provisions. However, in no event may an Award be granted under the Plan on or after the tenth (10th) anniversary of the Effective Date (but unless otherwise expressly provided in the Plan or in an applicable Award Agreement, any
Award granted prior to the tenth (10th) anniversary of the Effective Date may extend beyond such date, and the authority of the Committee to amend, alter, adjust, suspend, discontinue or terminate any such Award, or to waive any conditions or rights
under any such Award, and the authority of the Board to amend the Plan with respect to such Award, shall extend beyond such date). 
 2.
Definitions 
 The following terms shall have the meanings set forth below: 

2.1 “Acquired Organization” means an entity that was acquired by the Company through a merger, consolidation, combination, exchange of
shares, acquisition or other business transaction. 
 2.2 “Acquired Plan” means the incentive plan established by an Acquired
Organization or any awards outstanding thereunder. 
 2.3 “Affiliate” means a corporation or other entity that, directly or through
one or more intermediaries, controls, is controlled by or is under common control with, the Company. 
 2.4 “Articles of Association”
means the articles of association of the Company, as amended or restated. 
 2.5 “Award” means, individually or collectively, a grant
under this Plan of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Share Units, or Other Awards. 

 2.6 “Award Agreement” means any written agreement, contract, certificate or other
instrument or document, which may be in electronic format, evidencing the terms and conditions of an Award granted under the Plan. 
 2.7
“Beneficial Owner” or “Beneficial Ownership” shall have the meaning ascribed to such term in Rule13d-3 and Rule 13d-5 of the Exchange
Act. 
 2.8 “Beneficiary” means a person named by a Participant who is entitled to receive payments or other benefits or exercise
rights that are available under the Plan in the event of such Participant’s death. If no such person is named by a Participant, or if no Beneficiary designated by such Participant is eligible to receive payments or other benefits or exercise
rights that are available under the Plan at such Participant’s death, such Participant’s Beneficiary shall be such Participant’s estate. 

2.9 “Board” or “Board of Directors” means the Board of Directors of the Company. 

2.10 “Cause” means: 

(i) If the Participant is a party to a written employment, service or other agreement with the Company or its Affiliates and
such agreement provides for a definition of Cause, the definition contained therein; or 
 (ii) In the absence of any
employment agreement between a Participant and the Employer otherwise defining Cause, (i) acts of personal dishonesty, gross negligence or willful misconduct on the part of a Participant in the course of his or her employment or services;
(ii) a Participant’s engagement in conduct that results, or could be reasonably expected to result, in material injury to the reputation or business of the Company or its Affiliates; (iii) misappropriation by a Participant of the
assets or business opportunities of the Company or its Affiliates; (iv) embezzlement or fraud committed by a Participant, at his or her direction, or with his or her personal knowledge; (v) a Participant’s conviction by a court of
competent jurisdiction of, or pleading “guilty” or “no contest” to, (x) a felony, or (y) any other criminal charge (other than minor traffic violations) that has, or could be reasonably expected to have, an adverse
impact on the performance of the Participant’s duties to the Company or its Affiliates; or (vi) failure by a Participant to follow the lawful directions of a superior officer or the Board. Unless an applicable employment agreement
otherwise provides, the Committee, in its absolute discretion, will determine the effect of all matters on questions relating to whether a Participant has been discharged for Cause. 

2.11 “Change in Control” of the Company shall mean the occurrence of any one or more of the following events: 

(i) any Person becomes the Beneficial Owner (except that a Person shall be deemed to be the Beneficial Owner of all shares that
any such Person has the right to acquire pursuant to any agreement or arrangement or upon exercise of conversion rights, warrants or options or otherwise, without regard to the sixty (60) day period referred to in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company, representing fifty percent (50%) or more of the combined voting power of such entity’s then outstanding securities; 

 (ii) during any twelve (12) month period, a majority of the members of
the Board is replaced by individuals who were not members of the Board at the beginning of such twelve (12) month period and whose election by the Board or nomination for election by the Company’s shareholders was not approved by a vote of
at least a majority of the directors then still in office who either were directors at the beginning of such twelve (12) month period or whose election or nomination for election was previously so approved; 

(iii) the consummation of a merger or consolidation of the Company with any other entity, other than a merger or consolidation
that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving or resulting entity) fifty percent
(50%) or more of the combined voting power of the surviving or resulting entity outstanding immediately after such merger or consolidation; or 

(iv) the consummation of a sale or disposition of all or substantially all of the assets of the Company, other than such a sale
or disposition that would result in the voting securities of the Company outstanding immediately prior thereto representing fifty percent (50%) or more of the combined voting power of the acquiring entity outstanding immediately after such a sale or
disposition. 
 2.12 “Code” means the Internal Revenue Code of 1986, as amended from time to time. Any reference to a section of the
Code shall be deemed to include a reference to any regulations promulgated thereunder. 
 2.13 “Committee” means the Compensation
Committee of the Board or such other committee as may be designated by the Board to administer the Plan. If the Committee does not exist or cannot function for any reason or if the Board withdraws the Committee’s authority to administer the
Plan, references to the Committee shall mean the Board or such other committee of the Board as designated by the Board. 
 2.14 “Common
Stock” means the ordinary shares of the Company with a nominal value of $1 per share, fully paid-up, or any security issued by the Company in substitution or exchange therefor or in lieu thereof. 

2.15 “Company” means Perimeter Solutions SA, a public company limited by shares duly incorporated and validly existing under the laws
of the Grand Duchy of Luxembourg having its registered office at 12E, rue Guillaume Kroll, L-1882 Luxembourg, Grand Duchy of Luxembourg and registered with the Registre de Commerce et des
Sociétés, Luxembourg (Luxembourg Trade and Companies Register) under number B 256.548, and any successor thereto. 
 2.16
“Continuous Service” means the absence of any interruption or termination of service as an Employee, Director or Key Person. Continuous Service Status shall not be considered interrupted in the case of: (i) a statutory leave of
absence or a sick leave; (ii) military leave; (iii) any other leave of absence approved by the Committee, provided that such leave is for a 

 
period of not more than ninety (90) days, unless reemployment upon the expiration of such leave is guaranteed by contract or statute, or unless provided otherwise pursuant to Company policy
adopted from time to time; or (iv) in the case of transfers between locations of the Company or between the Company, its Affiliates or their respective successors. A change in the capacity in which the Participant renders services to the
Company, its Affiliates or their respective successors as an Employee, Director or Key Person will not constitute an interruption of Continuous Service Status. 

2.17 “Deed of Incorporation” means the deed of incorporation of the Company enacted on 21 June 2021 before Maître Danielle
Kolbach, notary residing in Junglinster, Grand Duchy of Luxembourg. 
 2.18 “Director” means a member of the Board. 

2.19 “Disability” means: 

(i) If the Participant is a party to a written employment or service agreement with the Company or its Affiliates and such
agreement provides for a definition of Disability, the definition contained therein; 
 (ii) If no written employment or
service agreement exists, or if such employment or service agreement does not define Disability, the definition contained in the Award Agreement; or 

(iii) If no definition is provided by application of clauses (i) and (ii) of this section, then Participant’s
physical or mental incapacity that renders him or her unable, with or without accommodation, for a period of 90 (ninety) consecutive days or an aggregate of one hundred and twenty (120) days in any three hundred and sixty-five
(365) consecutive calendar day period to perform his or her duties to the Company or any Affiliate. 
 Notwithstanding the foregoing, with respect to
any Incentive Stock Option, “Disability” shall mean “permanent and total disability” as defined in Section 22(e)(3) of the Code. To the extent the vesting or payment of any Award hereunder is accelerated by reason of a
Participant’s Disability, no such acceleration shall occur until the Participant experiences a Separation from Service. 
 2.20
“Effective Date” shall mean November 8, 2021. 
 2.21 “Employee” means any person employed by the Company or
any Affiliate, with the status of employment determined based upon such factors as are deemed appropriate by the Committee in its discretion, subject to any requirements of the Code or applicable laws. 

2.22 “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, and the rules, regulations and guidance
thereunder, or any successor act thereto. 

 2.23 “Fair Market Value” means, as of any date, the value of a Share, which shall be
an amount equal to the closing price of a Share on such date (or, if there is no reported sale on such date, on the last preceding date on which any reported sale occurred) on the principal stock market or exchange or inter-dealer quotation system
on which the Shares are quoted or traded. If Shares are not so quoted or traded, fair market value as determined by the Committee, and with respect to any property other than Shares, the fair market value of such property determined by such methods
or procedures as shall be established from time to time by the Committee. 
 2.24 “409A Guidance” means the regulations and other
guidance issued under Section 409A of the Code. 
 2.25 “Incentive Stock Option” or “ISO” means an option to
purchase Shares granted under Section 6, which is intended to meet the requirements of Section 422 of the Code. 
 2.26
“Insider” means an individual who is, on the relevant date, subject to Section 16 of the Exchange Act due to his or her status with the Company. 

2.27 “Key Person” means a consultant or advisor other than an Employee or Director who is a natural person and provides bona fide
services to the Company or a Subsidiary or an Affiliate (other than services in connection with the offer and sale of securities in a capital-raising transaction, or that directly or indirectly promote or maintain a market in the Company’s
securities). 
 2.28 “Nonqualified Stock Option” or “NQSO” means an option to purchase Shares granted under
Section 6 and which is not intended to be treated as an ISO under Section 422 of the Code. 
 2.29 “Other Award” means a
cash-based or stock-based award grant made pursuant to Section 10. 
 2.30 “Option” means an Incentive Stock Option or a
Nonqualified Stock Option, as described in Section 6. 
 2.31 “Option Price” means the price to be paid by a Participant and at
which a Share may be issued by the Company to a Participant upon the exercise of an Option. 
 2.32 “Participant” means an Employee,
Director or Key Person who is eligible to receive an Award or who has an outstanding Award granted under the Plan. 
 2.33 “Performance
Share” shall mean Shares awarded to a participant, subject to performance vesting goals or other vesting criteria as the Committee may determine pursuant to Section 9. 

2.34 “Performance Share Unit” means an Award which may be earned in whole or in part upon attainment of performance goals or other
vesting criteria as the Committee may determine and which may be settled for cash, Shares or other securities or a combination of the foregoing pursuant to Section 9. 

2.35 “Performance Period” means one or more periods of time, as the Committee may select, over which the attainment of one or more
performance goals will be measured for the purpose of determining a Participant’s right to and payment of a Performance Share Unit or Performance Share. 

 2.36 “Person” shall have the meaning ascribed to such term in Section 3(a)(9)
of the Exchange Act and used in Sections 13(d) and 14(d) thereof, including a “group” as defined in Section 13(d) thereof. 
 2.37
“Plan” means this 2021 Equity Incentive Plan of the Company 
 2.38 “Restricted Stock” means a Shares awarded to a
Participant pursuant to Section 8 herein. 
 2.39 “Restricted Stock Unit” or “RSU” means an unsecured and
unfunded promise to deliver a Share in the future pursuant to Section 8 herein, the terms and conditions of which shall be specified in the related Award Agreement. 

2.40 “Separation from Service” means a termination of the employment or other service relationship between the Participant and the
Company meeting the requirements of Section 409A(a)(2)(A)(i) of the Code. 
 2.41 “Share Reserve” shall have the meaning
ascribed to such term in Section 5.1. 
 2.42 “Shares” means shares of the Common Stock. 

2.43 “Stock Appreciation Right” or “SAR” means an Award, granted alone and designated as a SAR, pursuant to the terms
of Section 7. 
 2.44 “Subsidiary” means any corporation, partnership, joint venture, or other entity in which the Company
either directly or indirectly controls at least fifty percent (50%) of the voting interest or owns at least fifty percent (50%) of the value or capital or profits interest. 

2.45 “Substitute Award” means an Award granted in assumption of, or in substitution for, an outstanding award previously granted by an
Acquired Organization. 
 2.46 “Successor Corporation” shall have the meaning ascribed to such term in Section 12.1. 

3. Eligibility and Participation 
 3.1
Eligibility. Persons eligible to participate in this Plan include: 
 (i) All Employees, Directors and Key Persons of
the Company or an Affiliate. 
 (ii) Holders of equity-based awards granted by an Acquired Organization are eligible for
grants of Substitute Awards under the Plan to the extent permitted under applicable listing standards of any stock market or exchange on which the Shares are listed. Subject to such applicable listing standards, the terms and conditions of such
Substitute Awards shall be determined by the Committee in its sole discretion. 

 3.2 Participation. 

(i) Subject to the provisions of the Plan, the Committee may from time to time select from all eligible Employees, Directors
and Key Persons, those to whom Awards shall be granted and shall determine the nature and amount of each Award, and Awards may be granted to Participants at any time and from time to time as shall be determined by the Committee, including in
connection with any other compensation program established by the Company. 
 (ii) Eligibility for participation in this Plan
is not a guaranty or grant of a right to be selected to receive an Award, and being selected to receive an Award is not a representation or guaranty of being selected to receive any additional Awards. Selection is at the sole discretion of the
Committee. 
 4. Administration 
 4.1
General. The Plan shall be administered by the Committee. 
 4.2 Authority of the Committee. Subject to the terms of the Plan and
applicable law, the Committee (or, to the extent permitted hereby, its delegate) shall have full power and authority to: 

(i) designate Participants; 

(ii) determine the type or types of Awards to be granted to each Participant under the Plan; 

(iii) determine the number of Shares to be covered by (or with respect to which payments, rights or other matters are to be
calculated in connection with) Awards; 
 (iv) determine the terms and conditions of any Award; 

(v) determine whether, to what extent and under what circumstances Awards may be settled or exercised in cash, Shares, other
Awards, other property, net settlement, or any combination thereof, or canceled, forfeited or suspended, and the method or methods by which Awards may be settled, exercised, canceled, forfeited or suspended; 

(vi) determine whether, to what extent and under what circumstances a tax withholding obligation may be satisfied in cash,
Shares, other Awards, or other property; 
 (vii) determine whether, to what extent and under what circumstances cash,
Shares, other Awards, other property and other amounts payable with respect to an Award under the Plan shall be deferred either automatically or at the election of the holder thereof or of the Committee; 

(viii) interpret, administer and reconcile any inconsistency in, correct any defect in and/or supply any omission in the Plan
and any instrument or agreement relating to, or Award made under, the Plan; 

 (ix) establish, amend, suspend or waive such rules and regulations and
appoint such agents as it shall deem appropriate for the proper administration of the Plan; and 
 (x) make any other
determination and take any other action that the Committee deems necessary or desirable for the administration of the Plan. 
 4.3 Delegation.
The Committee may delegate its power, authority and duties as identified herein to a subcommittee, except (i) for the power and authority to grant Awards to Insiders (unless the delegation is to a subcommittee that complies with the exemption
requirements of Rule 16b-3, as such regulations may be amended from time to time or any successors thereto) and (ii) as otherwise prohibited by law. In addition to the delegation authority provided by the
previous sentence, to the extent permitted by applicable law or rule of the applicable stock market or exchange on which the Shares are listed, the Committee may delegate to one or more officers of the Company the authority to grant Options, SARs,
Restricted Stock and Restricted Stock Units to Participants that are not Insiders. 
 4.4 Decisions Binding. All determinations and decisions
made by the Board, the Committee or the Committee’s delegate pursuant to the provisions of the Plan and all related orders and resolutions of the Board, the Committee or the Committee’s delegate shall be final, conclusive and binding on
all persons, including the Company, its stockholders, Employees, Directors, Key Persons and their estates and beneficiaries. 
 4.5 Committee
Composition. Any grant by the Committee to an Insider shall require the approval of (i) a Committee that is composed solely of two (2) or more members who are non-employee directors within the
meaning of Rule 16b-3 under the Exchange Act or (ii) the full Board. The Board may designate one or more directors as alternate members of the Committee who may replace any absent or disqualified member
at any meeting of the Committee. 
 5. Shares Subject to the Plan and Maximum Awards 

5.1 Number of Shares Available for Grants. Subject to adjustment in accordance with Section 5.2, the maximum aggregate number of Shares that
may be granted pursuant to Awards shall not exceed 32,000,000 Shares (the “Share Reserve”). All Shares are authorized for issuance under the Plan and may be used for any type of Award under the Plan, and any or all of the Shares
reserved for issuance under the Plan shall be available for issuance pursuant to the ISOs. 
 The Share Reserve shall not be reduced for Substitute Awards.
Any shares of stock of an Acquired Organization available for future awards under an Acquired Plan (as adjusted and converted into Shares in accordance with the terms of the business transaction) shall be added to the number of Shares available for
Awards under the Plan, subject to applicable stockholder approval and stock exchange requirements, unless the terms of the business transaction require such Acquired Plan to be maintained as a separate plan following the completion of the business
transaction. 
 5.2 Adjustments in Authorized Shares. If the Company effects a subdivision or consolidation of Shares or other capital
adjustment, the number and class of Shares which may be delivered under Section 5.1, the number and class of and/or price of Shares subject to outstanding Awards granted under the Plan, and the Award limits set forth in Sections 5.2, shall

 
be adjusted in the same manner and to the same extent as all other Shares. If there are material changes in the capital structure of the Company resulting from: (i) the payment of a special
dividend (other than regular quarterly dividends) or other distributions to stockholders without receiving consideration therefore; (ii) the spin-off of a Subsidiary; (iii) the sale of a substantial
portion of the Company’s assets; (iv) a merger or consolidation in which the Company is not the surviving entity; or (v) other extraordinary non-recurring events affecting the Company’s
capital structure and the value of Shares, the Committee shall make equitable adjustments in the number and class of Shares which may be delivered under Section 5.1, the number and class of and/or price of Shares subject to outstanding Awards
granted under the Plan, and the Award limits set forth in Sections 5.2, to prevent the dilution or enlargement of the rights of Award recipients. Following any such adjustment, the number of Shares subject to any Award shall always be a whole
number. No adjustment shall be made to an Option or SAR to the extent that it causes such Option or SAR to provide for a deferral of compensation subject to Section 409A of the Code and the 409A Guidance. 

5.3 Increase to Share Reserve. If any Shares subject to an Award are forfeited before vesting or any Award otherwise expires, terminates or is
cash-settled or cancelled without the issuance of such Shares to a Participant, such Shares, to the extent of any such forfeiture, expiration, termination, cash-settlement or cancellation, shall again be available for grant under the Plan and be
added to the Share Reserve. 
 Shares withheld by the Company under an Award shall be deemed to have not been delivered to the Participant and shall be added
to the Share Reserve. 
 5.4 Character of Shares. Any Shares issued hereunder may consist, in whole or in part, of authorized and unissued
shares, treasury shares or shares purchased in the open market or otherwise. 
 5.5 Maximum Awards for Directors. The maximum aggregate number
of Shares subject to Awards granted during a single fiscal year to any Director who is not an Employee, taken together with any cash fees paid to such Director during such fiscal year, shall not exceed $1,000,000 in total value (calculating the
value of any such Awards based on the grant date Fair Market Value of such Awards for financial reporting purposes), in each case for service as a Director and not as a bona fide consultant or advisor to the Company. 

5.6 Conflict of Interest. Where a member of the Committee has a direct or indirect financial interest conflicting with that of the Company (the
“Conflicting Committee Member”) in either (i) the issuance of Awards to such Conflicting Committee Member or (ii) the issuance of Shares to such Conflicting Committee Member further to an Option exercise, the Conflicting
Committee Member must advise the Committee thereof and cause a record of her/his statement to be included in the minutes of the meeting and she/he may not take part in these deliberations. The provisions of article
441-12 of the Luxembourg law of 10 August 1915 on commercial companies as amended shall apply. 

 6. Options 

6.1 Grant of Options. Options may be granted to Participants in such number, upon such terms, and at such times as determined by the Committee;
provided, however, that ISOs may be granted only to Participants who are Employees of the Company or a Subsidiary that is a “subsidiary” of the Company within the meaning of Section 424(f) of the Code. ISOs shall not be granted to any
person who owns or is deemed to own pursuant to Section 424(d) of the Code stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any of its Affiliates, unless the exercise
price of the option is at least one hundred and ten percent (110%) of the Fair Market Value of a Share at the grant date and the option is not exercisable after the expiration of five years from the grant date. To the extent that the aggregate Fair
Market Value (determined at the time of grant) of Shares with respect to which ISOs are exercisable for the first time by any Participant during any calendar year (under all plans of the Company and its Affiliates) exceeds $100,000, the Options or
portions thereof which exceed such limit (according to the order in which they were granted) shall be treated as NQSOs. 
 Notwithstanding the foregoing, the
Company shall have no liability to any Participant or any other person if an Option designated as an ISO fails to qualify as such at any time or if an Option is determined to constitute “nonqualified deferred compensation” within the
meaning of Section 409A of the Code and the terms of such Option do not satisfy the requirements of Section 409A of the Code. 
 6.2
Award Agreement. Options granted under this Plan shall be evidenced by an Award Agreement, which shall specify whether the Option is intended to be an ISO or a NQSO. 

6.3 Option Price. Except with respect to an Option that is a Substitute Award, the Option Price for each Option shall be at least equal to one
hundred percent (100%) of the Fair Market Value of a Share on the date as of which the Option is granted (or, in the case of an ISO, granted to a person identified in Section 6.1 above, one hundred and ten percent (110%) of the Fair Market
Value of a Share). Notwithstanding the foregoing, an ISO may be granted with a lower Option Price if such ISO is granted pursuant to an assumption or substitution for another option in a manner satisfying the provisions of Section 424(a) of the
Code, and a NQSO may be granted with a lower Option Price if such NQSO is a Substitute Award granted in a manner satisfying the provisions of Section 409A of the Code and Treasury Regulation
1.409A-1(b)(5)(v)(D). 
 6.4 Duration of Options. Each Option shall expire at such time as the
Committee shall determine at the time of grant; provided, however, that no Option shall be exercisable after the expiration of the ten (10) year period beginning on the date of its grant. If determined by the Committee in its discretion, on
such terms and conditions and under such circumstances as the Committee shall establish, which may be applied differently among Participants or Awards, Options will be deemed exercised by the Participant (or in the event of the death of or
authorized transfer by the Participant, by the Beneficiary or transferee) on the expiration date of the Option using a net share settlement (or net settlement) method of exercise to the extent that as of such expiration date the Option is vested and
exercisable and the per share exercise price of the Option is below the Fair Market Value of a Share on such expiration date. 

 6.5 Vesting and Exercisability of Options. Options shall become vested and exercisable in such
manner, on such date or dates, or upon the achievement of performance goals or other vesting provisions, and be subject to such other restrictions and conditions, in each case, as may be determined by the Committee, which need not be the same for
each grant or for each Participant, and set forth in the Award Agreement. 
 6.6 Exercise of Options. Options may be exercised upon whatever
terms and conditions the Committee, in its sole discretion, imposes upon them. 
 6.7 Payment. Unless otherwise provided under the terms of an
Award Agreement, or as otherwise determined by the Committee, the Option Price shall be payable to the Company in full at the Participant’s option, either: (i) in cash or its equivalent, (ii) by tendering previously acquired Shares
having an aggregate value at the time of exercise equal to the total Option Price, (iii) through a reduction in the number of Shares received through the exercise of the Option (net share settlement), or (iv) by a combination of (i), (ii)
and (iii). Subject to any governing rules or regulations, as soon as practicable after receipt of notification of exercise and full payment, the Company shall issue the Shares in an appropriate amount based upon the number of Shares to be issued to
the Participant under the Option(s). 
 In the event that a Participant chooses option (ii) above and unless otherwise specifically provided in the
Award Agreement, the Participant shall tender only Shares that have been held for more than six months (or such longer or shorter period of time required to avoid a change to earnings for financial accounting purposes). 

7. Stock Appreciation Rights (SARs) 
 7.1
Grant of SARs. SARs may be granted to Participants in such number, upon such terms and at such times as determined by the Committee, it being noted that section 5.6 of the Plan shall apply to such grant in any case. A SAR granted in
connection with an Option shall become exercisable, be transferable and shall expire according to the same vesting schedule, transferability rules and expiration provisions as the corresponding Option. A SAR granted independent of an Option shall
become exercisable, be transferable and shall expire in accordance with a vesting schedule, transferability rules and expiration provisions as established by the Committee and reflected in an Award Agreement. Except with respect to an SAR that is a
Substitute Award and is granted in a manner that satisfies Section 409A of the Code and Treasury Regulation 1.409A-1(b)(5)(v)(D), the grant price of a SAR shall be at least equal to the Fair Market Value
of a Share on the date of grant of the SAR 
 7.2 Vesting and Exercisability of SARs. SARs shall become vested and exercisable at such times
and conditions and be subject to such restrictions and conditions as the Committee shall in each instance approve, which need not be the same for each grant or for each Participant, as set forth in the Award Agreement. 

7.3 Exercise of SARs. SARs may be exercised upon whatever terms and conditions the Committee, in its sole discretion, imposes upon them, it being
noted that section 5.6 of the Plan shall apply to such exercise in any case. 

 7.4 Duration of SARs. The term of a SAR shall be determined by the Committee, in its sole
discretion; provided, however, that such term shall not exceed ten (10) years. If determined by the Committee in its discretion, on such terms and conditions and under such circumstances as the Committee shall establish, which may be applied
differently among Participants or Awards, SARs will be deemed exercised by the Participant (or in the event of the death of or authorized transfer by the Participant by the Beneficiary or transferee) on the expiration date of the SAR to the extent
that as of such expiration date the SAR is vested and exercisable and the per share grant price of the SAR is below the Fair Market Value of a Share on such expiration date. 

7.5 Payment of SAR Amount. Upon exercise of a SAR, a Participant shall be entitled to receive payment from the Company in an amount determined by
multiplying the difference between the Fair Market Value of a Share on the date of exercise over the grant price, by the number of Shares with respect to which the SAR is exercised. 

At the discretion of the Committee, the payment upon exercise of a SAR may be in cash, in Shares of equivalent value, or in some combination thereof. The
Committee’s determination regarding the form of payout shall be set forth in the Award Agreement pertaining to the grant of the SAR. 
 8.
Restricted Stock and Restricted Stock Units (RSUs) 
 8.1 Grant of Restricted Stock or RSUs. Restricted Stock or RSUs may be granted
to Participants in such amounts, upon such terms and at such times as determined by the Committee, it being noted that section 5.6 of the Plan shall apply to such grant in any case. 

8.2 Restrictions. The Committee shall impose conditions and/or restrictions on Restricted Stock or RSUs as it may deem advisable including,
without limitation, time-based restrictions and/or restrictions based upon the achievement of other specific goals or circumstances. Restricted Stock or RSUs shall be forfeited to the extent that a Participant fails to satisfy the applicable
conditions and/or restrictions. All such conditions and/or restrictions shall be set forth in the applicable Award Agreement. 
 Any share of Restricted
Stock granted under the Plan may be evidenced in such manner as the Committee may deem appropriate, including book-entry registration or issuance of a stock certificate or certificates. In the event any stock certificate is issued in respect of
shares of Restricted Stock granted under the Plan, such certificate shall be registered in the name of such Participant and shall bear an appropriate legend referring to the terms, conditions and restrictions applicable to such Restricted Stock. The
Company may retain possession of Shares of Restricted Stock until such time as all conditions and/or restrictions applicable to such Shares have been satisfied. 

8.3 Lapse of Restrictions, Payment of Restricted Stock or RSUs. Except as otherwise provided in the Award Agreement or as required by applicable
law, Shares of Restricted Stock shall become freely transferable by the Participant as soon as practicable after all applicable conditions and/or restrictions have been satisfied. Except as otherwise provided in the Award Agreement or as required by
applicable law, RSUs shall be settled as soon as practicable after all applicable conditions and/or restrictions with respect to such RSUs have been satisfied, in the form of cash or in Shares (or in a combination thereof) as determined by the
Committee and set forth in the Award Agreement. If a cash payment is made in lieu of delivering Shares, the amount of such payment shall be equal to the Fair Market Value of the Shares as of the date on which all applicable conditions and/or
restrictions have been satisfied. 

 9. Performance Shares and Performance Share Units 

9.1 Grant of Performance Shares/Performance Share Units. Performance Shares and Performance Share Units may be granted to Participants in such
amounts, upon such terms and at such times as determined by the Committee, it being noted that section 5.6 of the Plan shall apply to such grant in any case. 

9.2 Performance Objectives and Other Terms. The Committee will set performance objectives or other vesting provisions in its discretion which,
depending on the extent to which they are met, will determine the number or value of Performance Shares or Performance Share Units that will be paid out to the Participants. Performance Share Units may be denominated as a cash amount, a number of
Shares, a number of units referencing a cash amount, a number of Shares or other property, or a combination thereof. The time period during which the performance objectives or other vesting provisions must be met will be called the
“Performance Period.” Each Award of Performance Shares or Performance Share Units will be evidenced by an Award Agreement that will specify the Performance Period, and such other terms and conditions as the Committee will determine.
The Committee may set performance objectives based upon the achievement of Company-wide, divisional, business unit or individual goals, applicable federal or state securities laws, or any other basis determined by the Committee in its discretion.
After the grant of Performance Shares or Performance Share Units, the Committee, in its sole discretion, may reduce or waive any performance objectives or other vesting provisions for such Performance Shares or Performance Share Units. Any
Performance Shares granted under the Plan may be evidenced in such manner as the Committee may deem appropriate, including book-entry registration or issuance of a stock certificate or certificates. In the event any stock certificate is issued in
respect of the Performance Shares granted under the Plan, such certificate shall be registered in the name of such Participant and shall bear an appropriate legend referring to the terms, conditions and restrictions applicable to such Performance
Shares. The Company may retain possession of Performance Shares until such time as all conditions and/or restrictions applicable to such Performance Shares have been satisfied. 

9.3 Lapse of Restrictions, Payment of Performance Shares/Performance Share Units. Except as otherwise provided in the Award Agreement or as
required by applicable law, Performance Shares shall become freely transferable by the Participant as soon as practicable after all applicable after the expiration of the applicable Performance Period and a determination has been made by the
Committee as to the extent to which the performance conditions and/or restrictions have been satisfied. Except as otherwise provided in the Award Agreement or as required by applicable law, payment of earned Performance Share Units will be made as
soon as practicable after the expiration of the applicable Performance Period and a determination is made by the Committee as to the extent to which the Performance Share Units have been earned. The Committee, in its sole discretion, may pay earned
Performance Share Units in the form of cash, in Shares (which have an aggregate Fair Market Value equal to the value of the earned Performance Share Units at the close of the applicable Performance Period) or in a combination thereof. 

 10. Other Awards 

The Committee may grant to Participants Other Awards that are denominated in cash or Shares or valued in whole or in part by reference to or are otherwise
based upon Shares, either alone or in addition to other Awards granted under this Plan. Other Awards may be settled in Shares, cash or any other form of property, as the Committee shall determine in its sole discretion. Other Awards may be granted
for past services, in lieu of bonus or other cash compensation, as directors’ compensation or for any other valid purpose as determined by the Committee. Subject to this Plan, the Committee shall have sole and complete authority to determine
the Employees, Directors and Key Persons to whom and the time or times at which Other Awards shall be made, the number of Shares to be granted pursuant to such Other Awards and all other terms and conditions of Other Awards, including whether such
Other Awards are made with or without vesting requirements or require payment of a specified purchase price. Other Awards shall be subject to such other terms and conditions as the Committee shall deem advisable or appropriate, consistent with this
Plan as herein set forth. 
 11. Provisions Applicable to All Awards 

11.1 Award Agreement. Unless the Committee determines otherwise, each Award shall be evidenced by an Award Agreement. Such Award Agreement shall
specify the terms of the Award, including without limitation, the type of the Award, the Option Price or grant price, if any, the number of Shares subject to the Award, the duration of the Award and such other provisions as the Committee shall
determine. 
 11.2 Continuous Service/Death/Disability. Each Award Agreement shall set forth the governing terms and conditions in the event of
the Participant’s death, Disability, and any interruption or termination of Participant’s Continuous Service. 
 11.3 Transferability of
Awards. Except as otherwise provided otherwise in the Award Agreement, Awards may not be sold, assigned, transferred, pledged or otherwise encumbered, other than by will or the laws of descent and distribution or pursuant to a qualified domestic
relations order (as defined in the Code or the Employment Retirement Income Security Act of 1974, as amended), and such Award may be exercised during the life of the Participant only by the Participant or the Participant’s guardian or legal
representative. 
 11.4 Restrictive Legends. All certificates for Shares and/or other securities delivered under the Plan pursuant to any Award
or the exercise thereof shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the Plan or the rules, regulations and other requirements of the Securities and Exchange Commission, any stock
market or exchange upon which such Shares or other securities are then quoted, traded or listed, and any applicable securities laws, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate reference to
such restrictions. 
 11.5 No Fractional Shares. No fractional Shares shall be issued or delivered pursuant to the Plan. The Committee shall
determine whether cash, additional Awards or other securities or property shall be issued or paid in lieu of fractional Shares or whether any fractional shares should be rounded, up or down, forfeited or otherwise eliminated. 

 12. Change in Control 

12.1 Effect of Change in Control. The Committee may (but shall not be required to) provide for accelerated vesting of an Award upon, or as a
result of specified events following, a Change in Control, either in an Award Agreement or in connection with the Change in Control. In the event of a Change in Control, the Committee may, among other alternatives, cause any Award: 

(i) to be canceled in consideration of a payment in cash or other consideration to such Participant who holds such Award in an
amount per share equal to the excess, if any, of the price or implied price per Share in a Change in Control over the per Share exercise or purchase price of such Award, which shall be paid immediately upon such cancellation and, if the price or
implied price per Share in a Change in Control is equal to or less than the per Share exercise or purchase price of such Award, the Award may be canceled for no consideration; or 

(ii) to be assumed or a substantially equivalent Award shall be substituted by the successor corporation or a parent or
subsidiary of such successor corporation (the “Successor Corporation”), unless the Successor Corporation does not agree to assume the award or to substitute an equivalent option or right (or agree to cashout the Award as provided in
clause (i)), in which case such Award shall become fully vested immediately prior to the Change of Control and shall thereafter terminate. An Award shall be considered assumed, without limitation, if, at the time of issuance of the stock or other
consideration upon a Change in Control, as the case may be, each holder of an Award would be entitled to receive upon exercise of the award the same number and kind of shares of stock or the same amount of property, cash or securities as such holder
would have been entitled to receive upon the occurrence of the transaction if the holder had been, immediately prior to such transaction, the holder of the number of Shares covered by the award at such time; provided that if the consideration
to be received in the transaction is not solely common stock of the Successor Corporation, the Committee may, with the consent of the Successor Corporation, provide for the consideration to be received upon exercise of the assumed award to be solely
common stock of the Successor Corporation. A transfer among the Successor Corporation and its affiliates shall not be deemed a termination of Participant’s Continuous Service. 

12.2 Termination, Amendment and Modification of Change in Control Provisions. Notwithstanding any other provision of this Plan or any Award
Agreement provision to the contrary, the provisions of this Section 12 may not be terminated, amended, or modified on or after the date of a Change in Control to affect adversely any Award granted under the Plan prior to the Change in
Control without the prior written consent of the Participant to whom the Award was made; except that no action shall be permitted under this Section 12.2 that would impermissibly accelerate or postpone payment of an Award subject to
Section 409A of the Code and the 409A Guidance. 

 13. Amendment, Modification and Termination 

13.1 Amendment, Modification and Termination. Subject to the terms of the Plan, the Board may at any time and from time to time, alter, amend,
suspend or terminate the Plan in whole or in part; provided that without the prior approval of the Company’s stockholders, no material amendment shall be made if stockholder approval is required by law, regulation or applicable listing
requirement of any stock exchange upon which the Common Stock is then listed; provided, further that notwithstanding any other provision of the Plan or any Award Agreement, no such alteration, amendment, suspension or termination shall be made
without the approval of the stockholders of the Company if the alteration, amendment, suspension or termination would increase the number of Shares available for Awards under the Plan, except as provided in Section 5. 

13.2 Awards Previously Granted. No termination, amendment, or modification of the Plan shall adversely affect in any material way any Award
previously granted under the Plan, without the prior written consent of the Participant to whom the Award was made. The Committee may amend any Award previously granted without the prior written consent of the Participant if such amendment does not
adversely affect the Award in any material way and may amend any Award previously granted with the written consent of the Participant. 
 Other than
pursuant to Section 5.2, the Committee shall not without the approval of the Company’s stockholders (i) lower the exercise or grant price per Share of an Option or SAR after it is granted, (ii) cancel an Option or SAR when the
exercise or grant price per Share exceeds the Fair Market Value of one Share in exchange for cash or another Award (other than in connection with a Change in Control as defined in Section 2.10), or (iii) take any other action with respect
to an Option that would be treated as a repricing under the rules and regulations of any stock exchange on which the Common Stock is then listed. 
 14.
Withholding 
 Unless the Participant elects to and satisfies such obligations otherwise, the Company shall make all payments or distributions
pursuant to the Plan to a Participant net of any applicable federal, state and local taxes required to be paid or withheld as a result of (a) the grant of any Award, (b) the exercise of an Option or Stock Appreciation Right, (c) the
delivery of Shares or cash, (d) the lapse of any restrictions in connection with any Award or (e) any other event occurring pursuant to the Plan. The Company or any Subsidiary or Affiliate shall have the right to withhold from wages or
other amounts otherwise payable to a Participant such withholding taxes as may be required by law, or to otherwise require the Participant to pay such withholding taxes. 

If the Participant shall fail to make such tax payments as are required, the Company or its Subsidiaries or Affiliates shall, to the extent permitted by law,
have the right to deduct any such taxes from any payment of any kind otherwise due to such Participant or to take such other action as may be necessary to satisfy such withholding obligations. The Committee shall be authorized to establish
procedures for election by Participants of methods to satisfy such tax payment obligations. 

 15. Indemnification 

Each person who is or shall have been a member of the Committee, or of the Board, shall be indemnified and held harmless by the Company (to the extent
permissible under applicable law) against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by him or her in connection with or resulting from any bona fide claim, action, suit, or proceeding against such
person or against the Company and in which he or she may be involved by reason of any action taken or failure to act by him or her under the Plan in his or her capacity as a member of the Committee or of the Board and against and from any and all
amounts paid by him or her in settlement thereof, with the Company’s approval, or paid by him or her in satisfaction of any judgment in any such action, suit, or proceeding against him or her, provided he or she shall give the Company an
opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to
which such persons may be entitled under the Company’s Articles of Association, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless. 

16. Waiver of Jury Trial 
 BY ACCEPTING AN AWARD
UNDER THE PLAN, EACH PARTICIPANT WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM CONCERNING ANY RIGHTS UNDER THE PLAN AND ANY AWARD, OR UNDER ANY AMENDMENT, WAIVER, CONSENT, INSTRUMENT, DOCUMENT OR OTHER AGREEMENT
DELIVERED OR WHICH IN THE FUTURE MAY BE DELIVERED IN CONNECTION THEREWITH, AND AGREES THAT ANY SUCH ACTION, PROCEEDINGS OR COUNTERCLAIM SHALL BE TRIED BEFORE A COURT AND NOT BEFORE A JURY. BY ACCEPTING AN AWARD UNDER THE PLAN, EACH PARTICIPANT
CERTIFIES THAT NO OFFICER, REPRESENTATIVE OR ATTORNEY OF THE COMPANY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT THE COMPANY WOULD NOT, IN THE EVENT OF ANY ACTION, PROCEEDING OR COUNTERCLAIM, SEEK TO ENFORCE THE FOREGOING WAIVERS. 

17. Miscellaneous 
 17.1 Number.
Except where otherwise indicated by the context, the plural shall include the singular and the singular shall include the plural. 
 17.2
Severability. In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the
illegal or invalid provision had not been included. 
 17.3 Requirements of Law. The granting of Awards and the issuance of Shares under the
Plan shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. In the event that such laws, rules, and/or regulations prohibit the grant
of Awards and/or issuance of Shares under the Plan, or if such actions are prohibited by or approvals cannot be obtained from governmental agencies or national securities exchanges, the Company shall be relieved from liability for failure to grant
Awards and/or failure to issue and sell Shares upon exercise of an Award. 
 17.4 Governing Law. The Plan and all Awards will be governed by
and interpreted in accordance with the laws of the Grand Duchy of Luxembourg, without giving effect to principles of conflicts of law. 

 17.5 Plan Controls. Unless expressly stated otherwise in the Plan, in the event of any
conflict between the provisions of an Award Agreement and the Plan, the Plan shall control, and the conflicting provisions of the Award Agreement shall be null and void ab initio. 

17.6 Repayment of Awards; Forfeiture. The Committee hereby reserves the right to seek repayment or recovery of an Award, or the value received
pursuant to an Award, as appropriate, notwithstanding any contrary provision of the Plan, under any recovery, recoupment, clawback and/or other forfeiture policy maintained by the Company from time to time. In addition, any Award, or the value
received pursuant to an Award is also subject to any applicable law or regulation or the standards of any stock exchange on which the Shares are then listed that provide for any such recovery, recoupment, clawback and/or forfeiture. The Committee
may also specify in an Award Agreement that the Participant’s rights, payments and benefits with respect to an Award shall be subject to reduction, cancellation, forfeiture or recoupment upon the occurrence of certain events, in addition to
applicable vesting conditions of an Award. Such events may include, without limitation, breach of non-competition, non-solicitation, confidentiality or other restrictive
covenants that are contained in the Award Agreement or otherwise applicable to the Participant, a termination of the Participant’s employment for Cause, or other conduct by the Participant that is detrimental to the business or reputation of
the Company and/or its Affiliates. 
 17.7 Section 409A Compliance. It is intended that the Awards are either exempt from the requirements of
Section 409A of the Code and the 409A Guidance or will satisfy the requirements of Section 409A of the Code and the 409A Guidance (in form and operation) so that compensation deferred under an applicable Award (and applicable earnings)
shall not be included in income under Section 409A of the Code, and the Plan will be construed to that effect. Notwithstanding anything else in the Plan, if the Board determines a Participant to be one of the Company’s “specified
employees” under Section 409A of the Code at the time of such Participant’s Separation from Service in accordance with the identification date specified in the 409A Guidance and the amount hereunder is “deferred
compensation” subject to Section 409A, then any distribution that otherwise would be made to such Participant with respect to this Award as a result of such termination shall not be made until the date that is six months after such
Separation from Service or, if earlier, the date of the death of the Participant. 
 However, neither the Company nor the Committee shall have any obligation
to take any action to prevent the assessment of any excise tax or penalty on any person for any equity award under Section 409A of the Code. If an Award is subject to Section 409A of the Code and the 409A Guidance, the Award Agreement will
incorporate and satisfy the written documentation requirement of Section 409A of the Code and the 409A Guidance either directly or by reference to other documents. Notwithstanding the foregoing, the Company and the Committee shall not have any
liability to any Participant for taxes or penalties under Section 409A of the Code, and the Company and the Committee shall not have any obligation to indemnify any Participant for any taxes or penalties under Section 409A of the Code.

 17.8 Stockholder Rights. Except as provided in the Plan or an Award Agreement, no Participant or Beneficiary shall have any rights as a
stockholder with respect to Shares subject to an Award until such Shares are delivered to the Participant or the Beneficiary, and no adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property) or
distributions of other rights for which the record date is prior to the date such Shares are delivered. For the avoidance of doubt, an Award Agreement may provide the Participant or Beneficiary with dividend equivalent rights on such terms and
conditions as may be determined by the Committee. 

 17.9 No Employment or Other Service Rights. Nothing in the Plan or any instrument executed or
Award granted pursuant thereto shall confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Award was granted or shall affect the right of the Company or an Affiliate to
terminate (a) the employment of an Employee with or without notice and with or without Cause or (b) the service of a Director pursuant to the Deed of Incorporation or Articles of Association of the Company or the functional equivalent of
any governing documents of an Affiliate, and any applicable provisions of the corporate law of the state or country in which the Company or the Affiliate is incorporated, as the case may be. 

17.10 Sub-plans. The Committee may from time to time establish
sub-plans under the Plan for purposes of satisfying blue sky, securities, tax, or other laws of various jurisdictions in which the Company intends to grant Awards. Any
sub-plans shall contain such limitations and other terms and conditions as the Committee determines are necessary or desirable. All sub-plans shall be deemed a part of
the Plan, but each sub-plan shall apply only to the Participants in the jurisdiction for which the sub-plan was designed. 

17.11 Acceleration of Exercisability and Vesting. The Committee, as allowed under applicable law, shall have the power to accelerate the time at
which an Award may first be exercised or the time during which an Award or any part thereof will vest in accordance with the Plan, notwithstanding the provisions in the Award stating the time at which it may first be exercised or the time during
which it will vest. 
 17.12 Unfunded Plan. The Plan shall be unfunded. Neither the Company, the Board, nor the Committee shall be required to
establish any special or separate fund or to segregate any assets to assure the performance of their obligations under the Plan. 
 17.13
Disqualifying Dispositions. Any Participant who shall make a “disposition” under Section 424 of the Code of all or any portion of Shares acquired upon exercise of an ISO within two (2) years from the grant date of such ISO
or within one year after the issuance of the Shares acquired upon exercise of such ISO shall be required to immediately advise the Company in writing as to the occurrence of the sale and the price realized upon the sale of such Shares. 

17.14 Non-Uniform Treatment. The Committee’s determinations under the Plan need not be uniform and
may be made by it selectively among persons who are eligible to receive, or actually receive, Awards. Without limiting the generality of the foregoing, the Committee shall be entitled to make non-uniform and
selective determinations, amendments, and adjustments, and to enter into non-uniform and selective Award Agreements.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]